purmorphamine : A member of the class of purines that is purine substituted at C-2 by a 1-naphthyloxy group, at C-4 by a 4-morpholinophenylamino group, and at N-9 by a cyclohexyl group. [CHeBI]
Assay ID | Title | Year | Journal | Article |
AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1 ISSN: 2472-5560 | Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49 ISSN: 1091-6490 | Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49 ISSN: 1091-6490 | Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5 ISSN: 1521-0111 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5 ISSN: 1521-0111 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1347093 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347100 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347094 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347092 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173ISSN: 1872-9096 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | 2022 | The Journal of biological chemistry, 08, Volume: 298, Issue:8 ISSN: 1083-351X | |
AID1347089 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4 ISSN: 2211-1247 | A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
AID1347090 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347096 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347095 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347101 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347099 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347108 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347106 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347105 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347097 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173ISSN: 1872-9096 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID1347107 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49 ISSN: 1091-6490 | Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1347102 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347104 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347098 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173ISSN: 1872-9096 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
AID1347091 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID1347103 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 ISSN: 1949-2553 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
AID509545 | Agonist activity at hedgehog receptor | 2010 | Bioorganic & medicinal chemistry, Sep-15, Volume: 18, Issue:18 ISSN: 1464-3391 | Modulators of the hedgehog signaling pathway. |
AID502890 | Activation of Shh in smo-expressing MEF at 0.5 uM after 30 hrs by luciferase reporter assay | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID502894 | Ratio of EC50 for Shh in mouse Shh Light2 cells to EC50 for Shh in mouse Shh Light2 cells in presence of 100 nM 3-keto-N-aminoethyl-N'-aminocaproyldihydrocinnamoyl cyclopamine | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID502889 | Activation of Shh in smo gene-deficient MEF at 0.5 uM after 30 hrs by luciferase reporter assay | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID502885 | Activation of Shh in ptch1 gene-deficient MEF assessed as beta-galactosidase activity after 30 hrs by chemiluminescence assay in presence of 100 nM 3-keto-N-aminoethyl-N'-aminocaproyldihydrocinnamoyl cyclopamine | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID502884 | Activation of Shh in mouse Shh Light2 cells after 30 hrs by luciferase reporter gene assay | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID1321065 | Activity at Smo in mouse C3H10T1/2 cells assessed as induction of cell differentiation into osteoblast at 10 uM incubated for 6 days by alkaline phosphatase assay relative to GSA-10 | 2016 | European journal of medicinal chemistry, Oct-04, Volume: 121ISSN: 1768-3254 | Design, synthesis and biological characterization of a new class of osteogenic (1H)-quinolone derivatives. |
AID502891 | Inhibition of BODIPY-cyclopamine binding to Smo expressed in HEK293T cells after 1 hr by fluorescence microscopy | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID512617 | Induction of osteogenesis in mouse C3H10T1/2 cells assessed as induction of osteoblast specific marker alkaline phosphatase by immunofluorescence method | 2005 | Nature chemical biology, Jul, Volume: 1, Issue:2 ISSN: 1552-4450 | Diversity-oriented synthesis: exploring the intersections between chemistry and biology. |
AID502892 | Inhibition of BODIPY-cyclopamine binding to Smo N-terminal cysteine domain expressed in HEK293T cells at 5 uM after 4 hrs by fluorescence microscopy | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID502886 | Activation of Shh in mouse Shh Light2 cells assessed as beta-galactosidase activity after 30 hrs by luciferase reporter gene assay in presence of 100 nM 3-keto-N-aminoethyl-N'-aminocaproyldihydrocinnamoyl cyclopamine | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID502893 | Inhibition of BODIPY-cyclopamine binding to Smo C-terminal cytoplasmic domain expressed in HEK293T cells at 5 uM after 4 hrs by fluorescence microscopy | 2006 | Nature chemical biology, Jan, Volume: 2, Issue:1 ISSN: 1552-4450 | Purmorphamine activates the Hedgehog pathway by targeting Smoothened. |
AID1321064 | Activity at Smo in mouse C3H10T1/2 cells assessed as induction of cell differentiation into osteoblast incubated for 6 days by alkaline phosphatase assay | 2016 | European journal of medicinal chemistry, Oct-04, Volume: 121ISSN: 1768-3254 | Design, synthesis and biological characterization of a new class of osteogenic (1H)-quinolone derivatives. |
AID1347411 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7 ISSN: 1554-8937 | High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
bohemine | | purines | EC 2.7.11.22 (cyclin-dependent kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-chlorotheophylline | | organochlorine compound; purines | central nervous system stimulant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-fluoroadenine | | organofluorine compound; purines | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytidylyl-3',5'-adenosine | | nucleoside analogue; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uridylyl-(3'-5')-adenosine | | nucleoside analogue; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,n(6)-ethenodeoxyadenosine | | purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adenylyl-(2'-5')-uridine | | nucleoside analogue; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-morpholinoanilino)-6-cyclohexylaminopurine | | morpholines; purines; secondary amino compound; tertiary amino compound | adenosine A3 receptor antagonist; antineoplastic agent; Aurora kinase inhibitor; cell dedifferentiation agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(2R,3S,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-3-oxolanol | | 3'-deoxyribonucleoside; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mercaptopurine | | aryl thiol; purines; thiocarbonyl compound | anticoronaviral agent; antimetabolite; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzoic acid [5-(6-benzamido-9-purinyl)-3-fluoro-4-hydroxy-2-oxolanyl]methyl ester | | 3'-deoxyribonucleoside; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-mercapto-9-(tetrahydro-2-furyl)purine | | purines; thiocarbonyl compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-9-pentyl-3H-purine-6-thione | | purines; thiocarbonyl compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-cyclopentyl-3H-purine-6-thione | | purines; thiocarbonyl compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methylpurine | | purines | EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-chloropurine | | purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-deoxyadenylyl-(3'-5')-2'-deoxyadenosine | | nucleoside analogue; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
idelalisib | | aromatic amine; organofluorine compound; purines; quinazolines; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
agrocin 84 | | purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[9-[(3R)-3-oxolanyl]-8-(2,4,6-trifluoroanilino)-2-purinyl]amino]-1-cyclohexanol | | purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
valganciclovir | | L-valyl ester; purines | antiviral drug; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-methoxyphenyl)-6-sulfanylidene-1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one | | organosulfur compound; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guanylyl-(3'-5')-guanosine | | nucleoside analogue; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2'-deoxyguanylyl-(3'-5')-2'-deoxycytidine | | nucleoside analogue; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guanine ribonucleotidyl-(3'-5')-adenosine | | nucleoside analogue; purines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimorpholamine | | morpholines; ureas | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol | | benzyl alcohols; fatty amide; morpholines; secondary alcohol; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
doxapram | | morpholines; pyrrolidin-2-ones | central nervous system stimulant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hemicholinium 3 | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one | | chromones; morpholines; organochlorine compound | autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
minaprine | | morpholines; pyridazines; secondary amine | antidepressant; antiparkinson drug; cholinergic drug; dopamine uptake inhibitor; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
moclobemide | | benzamides; monochlorobenzenes; morpholines | antidepressant; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
molsidomine | | ethyl ester; morpholines; oxadiazole; zwitterion | antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenmetrazine | | morpholines | metabolite; sympathomimetic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pramoxine | | aromatic ether; morpholines | local anaesthetic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
linsidomine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
morpholine | | morpholines; saturated organic heteromonocyclic parent | NMR chemical shift reference compound | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trimetozine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trifenmorph | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenbutrazate | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tridemorph | | morpholines; tertiary amino compound | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
moricizine | | carbamate ester; morpholines; phenothiazines | anti-arrhythmia drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
morazone | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
delmopinol | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-morpholinopropylamine | | morpholines; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
morzid | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methoxy-morpholinyl-doxorubicin | | anthracycline antibiotic; morpholines; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
morphazinamide | | morpholines; pyrazines; secondary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
morpholinopropane sulfonic acid | | MOPS; morpholines; organosulfonic acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide | | carbodiimide; morpholines | cross-linking reagent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dextromoramide | | morpholines; N-acylpyrrolidine | opioid analgesic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
landiolol | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mosapride | | aromatic ether; benzamides; monochlorobenzenes; monofluorobenzenes; morpholines; secondary carboxamide; substituted aniline; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gefitinib | | aromatic ether; monochlorobenzenes; monofluorobenzenes; morpholines; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; epidermal growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pre 084 | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xamoterol | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
canertinib | | monochlorobenzenes; morpholines; organofluorine compound; quinazolines | antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
birb 796 | | aromatic ether; morpholines; naphthalenes; pyrazoles; ureas | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; immunomodulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Landiolol hydrochloride | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-2-Aminoethyl-morpholine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rocuronium | | 3alpha-hydroxy steroid; acetate ester; androstane; morpholines; quaternary ammonium ion; tertiary amino compound | drug allergen; muscle relaxant; neuromuscular agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
linezolid | | acetamides; morpholines; organofluorine compound; oxazolidinone | antibacterial drug; protein synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cp-640186 | | anthracenes; bipiperidines; morpholines; N-acylpiperidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-Morpholinyl(4-pentylcyclohexyl)methanone | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[5-[4-(dimethylamino)phenyl]-2-tetrazolyl]-N-[2-(4-morpholinyl)phenyl]acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(4-fluorophenyl)-1-methyl-2-imidazolyl]thio]-N-[2-(4-morpholinyl)phenyl]acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,4-dioxo-3-thiazolidinyl)-N-[4-(4-morpholinyl)phenyl]acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methylphenyl)-2-[5-[4-(4-morpholinyl)phenyl]-2-tetrazolyl]acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[4-morpholinyl(oxo)methyl]-2-pyranone | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(1,3-benzodioxol-5-ylmethylamino)-2-(4-morpholinyl)benzoic acid methyl ester | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(4-morpholinyl)phenyl]-2-thiophenesulfonamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(4-morpholinyl)-N-(pyridin-4-ylmethyl)aniline | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-amino-3-(4-methylphenyl)-2-sulfanylidene-5-thiazolyl]-(4-morpholinyl)methanone | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(1,3-dimethyl-2,6-dioxo-9-purinyl)-N-[2-(4-morpholinyl)-5-(trifluoromethyl)phenyl]acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
DND-167 dye | | morpholines | fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2,1,3-benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-methylphenyl)-N-[4-(4-morpholinyl)phenyl]-4-quinazolinamine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3-methylphenyl)-N-[4-(4-morpholinyl)phenyl]-4-quinazolinamine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[2,3-bis(2-furanyl)-6-quinoxalinyl]-3-[4-(4-morpholinyl)phenyl]thiourea | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[5-(5-chloro-2-methylphenyl)-2-furanyl]-N-[4-(4-morpholinyl)phenyl]methanimine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,4-dioxo-1H-pyrimidin-6-yl)-N-[2-(4-morpholinyl)ethyl]acetamide | | morpholines; pyrimidone; secondary carboxamide; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4-butylphenyl)-3-(4-morpholinyl)thiourea | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[[2-methoxy-4-(4-morpholinyl)phenyl]methylidene]-1,3-diazinane-2,4,6-trione | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2,2-dichloro-1-(3-fluoro-4-methylphenyl)ethenyl]-4-morpholinecarboxamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(methylthio)-3-pyridinecarboxylic acid [2-[2-(4-morpholinyl)-5-(trifluoromethyl)anilino]-2-oxoethyl] ester | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-hydroxy-1-naphthalenyl)methyl-methylamino]-N-[4-(4-morpholinyl)phenyl]acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2,5-diethoxy-4-morpholinophenyl)acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Benzo[b]thiophen-2-yl(morpholino)methanone | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-morpholinoanilino)-5-oxo-3-phenylpentanoic acid | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-morpholinophenyl)-N'-phenylurea | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N,N'-di[4-(2,6-dimethylmorpholino)phenyl]thiourea | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5,7-trimethyl-N-[4-morpholinyl(sulfanylidene)methyl]-1-adamantanecarboxamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(3-methylphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(4-methoxyphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[3-[(2-chlorophenoxy)methyl]phenyl]-(2,6-dimethyl-4-morpholinyl)methanone | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,6-dimethyl-4-thiophen-2-ylsulfonylmorpholine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[4-(dimethylamino)phenyl]-3-[4-(4-morpholinyl)anilino]pyrrolidine-2,5-dione | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2,4-dimethoxyphenyl)-3-[4-(4-morpholinyl)anilino]pyrrolidine-2,5-dione | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-chloro-4-(4-morpholinyl)phenyl]-1,1-dioxo-1,2-benzothiazol-3-amine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-[(2,6-dimethyl-4-morpholinyl)methyl]-5-thiazolo[3,2-a]pyrimidinone | | morpholines; thiazolopyrimidine | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(4-chlorophenyl)sulfonyl-N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]propanamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(methanesulfonamido)benzoic acid [1-[4-(4-morpholinyl)anilino]-1-oxopropan-2-yl] ester | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chloro-2-methylphenoxy)-N-[2-(4-morpholinyl)phenyl]propanamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-amino-5-morpholinomethyl-2-oxazolidinone | | morpholines; oxazolidinone | marine xenobiotic metabolite; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-ethyl-2-[[[3-(4-morpholinyl)-4-nitrophenyl]-oxomethyl]amino]-3-thiophenecarboxylic acid ethyl ester | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methyl-N-[4-(4-morpholinyl)phenyl]-2-quinolinimine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-morpholinecarboxylic acid [3-(6-amino-5-cyano-3-propan-2-yl-2,4-dihydropyrano[2,3-c]pyrazol-4-yl)phenyl] ester | | morpholines; pyranopyrazole | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-morpholinecarboxylic acid [3-(6-amino-5-cyano-3-ethyl-2,4-dihydropyrano[2,3-c]pyrazol-4-yl)phenyl] ester | | morpholines; pyranopyrazole | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(4-amino-3-ethyl-2-sulfanylidene-5-thiazolyl)-(4-morpholinyl)methanone | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
LSM-19878 | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-morpholinyl)-5-(1-piperidinylsulfonyl)benzoic acid [2-[2-(4-fluorophenyl)ethylamino]-2-oxoethyl] ester | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(4-morpholinyl)-3-nitro-N-(2-thiazolyl)benzamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(1-adamantyl)-N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[2,5-diethoxy-4-(4-morpholinyl)anilino]-1-(4-methyl-1-piperidinyl)-1-propanone | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-[bis(4-morpholinyl)phosphoryl]-1-methyl-2-pyrrolyl]-bis(4-morpholinyl)-sulfanylidenephosphorane | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-benzoyl-6-methyl-4-[4-(4-morpholinyl)phenyl]-3,4-dihydro-1H-pyrimidin-2-one | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone | | morpholines; naphthyl ketone; organic heterotricyclic compound; synthetic cannabinoid | analgesic; apoptosis inhibitor; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
molsidomine | | ethyl ester; morpholines; oxadiazole; zwitterion | antioxidant; apoptosis inhibitor; cardioprotective agent; nitric oxide donor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
DPI2 | | benzenes; morpholines; secondary carboxamide; tertiary amino compound; thiazolidinone | ferroptosis inducer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-methylphenyl)-4-[4-(4-morpholinyl)-3-nitrophenyl]-1-phthalazinamine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rivaroxaban | | aromatic amide; lactam; monocarboxylic acid amide; morpholines; organochlorine compound; oxazolidinone; thiophenes | anticoagulant; EC 3.4.21.6 (coagulation factor Xa) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pi103 | | aromatic amine; morpholines; organic heterotricyclic compound; phenols; tertiary amino compound | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zm 447439 | | aromatic ether; benzamides; morpholines; polyether; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; Aurora kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tae226 | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flumorph | | aromatic ether; enamide; morpholines; organofluorine compound; tertiary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epoxomicin | | morpholines; tripeptide | proteasome inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
MI-63 | | azaspiro compound; monochlorobenzenes; monofluorobenzenes; morpholines; oxindoles; pyrrolidines; secondary carboxamide | apoptosis inducer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chir 090 | | acetylenic compound; benzamides; hydroxamic acid; L-threonine derivative; morpholines | antimicrobial agent; EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor; lipopolysaccharide biosynthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carfilzomib | | epoxide; morpholines; tetrapeptide | antineoplastic agent; proteasome inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zstk474 | | benzimidazoles; morpholines; organofluorine compound; triamino-1,3,5-triazine | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4-bromophenyl)-3-[[[4-(4-morpholinyl)-3-nitrophenyl]-oxomethyl]amino]thiourea | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[(2-heptan-3-yl-1,3-dioxolan-4-yl)methyl]-4-methylmorpholin-4-ium | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(4-morpholinyl)phenyl]-3-imidazo[1,2-a]pyrazinamine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
buparlisib | | aminopyridine; aminopyrimidine; morpholines; organofluorine compound | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ku 0063794 | | benzyl alcohols; monomethoxybenzene; morpholines; pyridopyrimidine; tertiary amino compound | antineoplastic agent; mTOR inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gdc 0941 | | indazoles; morpholines; piperazines; sulfonamide; thienopyrimidine | EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lde225 | | aminopyridine; aromatic ether; benzamides; biphenyls; morpholines; organofluorine compound; tertiary amino compound | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quizartinib | | benzoimidazothiazole; isoxazoles; morpholines; phenylureas | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; necroptosis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
navitoclax | | aryl sulfide; monochlorobenzenes; morpholines; N-sulfonylcarboxamide; organofluorine compound; piperazines; secondary amino compound; sulfone; tertiary amino compound | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide | | aminopyrimidine; benzamides; morpholines; nitrile; secondary amino compound; tertiary amino compound | anti-anaemic agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cobicistat | | 1,3-thiazoles; carbamate ester; monocarboxylic acid amide; morpholines; ureas | P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol | | benzyl alcohols; morpholines; pyridopyrimidine; tertiary amino compound | antineoplastic agent; apoptosis inducer; mTOR inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alectinib | | aromatic ketone; morpholines; nitrile; organic heterotetracyclic compound; piperidines | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-fluorophenmetrazine | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
HG-10-102-01 | | aminopyrimidine; aromatic ether; monocarboxylic acid amide; morpholines; organochlorine compound; secondary amino compound | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
MLI-2 | | aromatic ether; cyclopropanes; indazoles; morpholines; pyrimidines; tertiary amino compound | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aprepitant | | (trifluoromethyl)benzenes; cyclic acetal; morpholines; triazoles | antidepressant; antiemetic; neurokinin-1 receptor antagonist; peripheral nervous system drug; substance P receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fosaprepitant | | (trifluoromethyl)benzenes; cyclic acetal; morpholines; phosphoramide; triazoles | antiemetic; neurokinin-1 receptor antagonist; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]-N-[4-(4-morpholinyl)phenyl]acetamide | | morpholines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ver 52296 | | aromatic amide; isoxazoles; monocarboxylic acid amide; morpholines; resorcinols | angiogenesis inhibitor; antineoplastic agent; Hsp90 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hydroxy-3-(5-((morpholin-4-yl)methyl)pyridin-2-yl)-1h-indole-5-carbonitrile | | hydroxyindoles; morpholines; nitrile; pyridines; tertiary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; tau aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quinacrine | | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vanilmandelic acid | | 2-hydroxy monocarboxylic acid; aromatic ether; phenols | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(2,4-dichlorophenoxy)butyric acid | | aromatic ether; monocarboxylic acid; organochlorine compound | agrochemical; phenoxy herbicide; synthetic auxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
win 52035 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
win 52084 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(nonyloxy)tryptamine | | aromatic ether; primary amino compound; tryptamines | serotonergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methylbufotenin | | aromatic ether; tertiary amino compound; tryptamine alkaloid | hallucinogen; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxytryptamine | | aromatic ether; primary amino compound; tryptamines | 5-hydroxytryptamine 2A receptor agonist; 5-hydroxytryptamine 2B receptor agonist; 5-hydroxytryptamine 2C receptor agonist; antioxidant; cardioprotective agent; human metabolite; mouse metabolite; neuroprotective agent; radiation protective agent; serotonergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro 48-8071 | | aromatic ether; aromatic ketone; bromobenzenes; monofluorobenzenes; olefinic compound; tertiary amino compound | antineoplastic agent; EC 5.4.99.7 (lanosterol synthase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rtki cpd | | aromatic ether; monochlorobenzenes; quinazolines | antineoplastic agent; antiviral agent; epidermal growth factor receptor antagonist; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amsacrine | | acridines; aromatic ether; sulfonamide | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid i | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one | | aromatic ether; benzoxazine; cyclic hydroxamic acid; lactol | allelochemical; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bufetolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bufexamac | | aromatic ether; hydroxamic acid | antipyretic; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bunitrolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bupranolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
verapamil | | aromatic ether; nitrile; polyether; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cgp 12177 | | aromatic ether; benzimidazoles; secondary alcohol; secondary amino compound | beta-adrenergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ciglitazone | | aromatic ether; thiazolidinone | antineoplastic agent; insulin-sensitizing drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cirazoline | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clofibrate | | aromatic ether; ethyl ester; monochlorobenzenes | anticholesteremic drug; antilipemic drug; geroprotector; PPARalpha agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clofibric acid | | aromatic ether; monocarboxylic acid; monochlorobenzenes | anticholesteremic drug; antilipemic drug; antineoplastic agent; herbicide; marine xenobiotic metabolite; PPARalpha agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
colchicine, (+-)-isomer | | acetamides; alkaloid; aromatic ether; carbotricyclic compound | microtubule-destabilising agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
croconazole | | aromatic ether; conazole antifungal drug; imidazole antifungal drug; monochlorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cypermethrin | | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound | agrochemical; molluscicide; pyrethroid ester acaricide; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
racemethorphan | | aromatic ether; morphinane alkaloid; morphinane-like compound; organic heterotetracyclic compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibucaine | | aromatic ether; monocarboxylic acid amide; tertiary amino compound | topical anaesthetic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dilacor xr | | acetate ester; aromatic ether; benzothiazepine; lactam; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
domiphen | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
donepezil | | aromatic ether; indanones; piperidines; racemate | EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nootropic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
epirizole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethacrynic acid | | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethoxyquin | | aromatic ether; quinolines | antifungal agrochemical; food antioxidant; genotoxin; geroprotector; herbicide; Hsp90 inhibitor; neuroprotective agent; UDP-glucuronosyltransferase activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethoxzolamide | | aromatic ether; benzothiazoles; sulfonamide | antiglaucoma drug; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-hexyloxybenzamide | | aromatic ether; benzamides | antifungal agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carbonyl cyanide p-trifluoromethoxyphenylhydrazone | | aromatic ether; hydrazone; nitrile; organofluorine compound | ATP synthase inhibitor; geroprotector; ionophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenofibrate | | aromatic ether; chlorobenzophenone; isopropyl ester; monochlorobenzenes | antilipemic drug; environmental contaminant; geroprotector; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenvalerate | | aromatic ether; carboxylic ester; monochlorobenzenes | pyrethroid ester acaricide; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flecainide | | aromatic ether; monocarboxylic acid amide; organofluorine compound; piperidines | anti-arrhythmia drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluoxetine | | (trifluoromethyl)benzenes; aromatic ether; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gallamine triethiodide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gemfibrozil | | aromatic ether | antilipemic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
haloprogin | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indomethacin | | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ipriflavone | | aromatic ether; isoflavones | bone density conservation agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ly 171883 | | acetophenones; aromatic ether; phenols; tetrazoles | anti-asthmatic drug; leukotriene antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mephenesin | | aromatic ether; glycerol ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methocarbamol | | aromatic ether; carbamate ester; secondary alcohol | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methoctramine | | aromatic ether; tetramine | muscarinic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methoxsalen | | aromatic ether; psoralens | antineoplastic agent; cross-linking reagent; dermatologic drug; photosensitizing agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metoprolol | | aromatic ether; propanolamine; secondary alcohol; secondary amino compound | antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mexiletine | | aromatic ether; primary amino compound | anti-arrhythmia drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
midodrine | | amino acid amide; aromatic ether; secondary alcohol | alpha-adrenergic agonist; prodrug; sympathomimetic agent; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clorgyline | | aromatic ether; dichlorobenzene; terminal acetylenic compound; tertiary amino compound | antidepressant; EC 1.4.3.4 (monoamine oxidase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nefazodone | | aromatic ether; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazoles | alpha-adrenergic antagonist; analgesic; antidepressant; serotonergic antagonist; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nimesulide | | aromatic ether; C-nitro compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nisoxetine | | aromatic ether; secondary amino compound | adrenergic uptake inhibitor; antidepressant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | | aromatic ether; C-nitro compound; sulfonamide | antineoplastic agent; cyclooxygenase 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
omeprazole | | aromatic ether; benzimidazoles; pyridines; sulfoxide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxprenolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pantoprazole | | aromatic ether; benzimidazoles; organofluorine compound; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pd 153035 | | aromatic amine; aromatic ether; bromobenzenes; quinazolines; secondary amino compound | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pentamidine | | aromatic ether; carboxamidine; diether | anti-inflammatory agent; antifungal agent; calmodulin antagonist; chemokine receptor 5 antagonist; EC 2.3.1.48 (histone acetyltransferase) inhibitor; NMDA receptor antagonist; S100 calcium-binding protein B inhibitor; trypanocidal drug; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenacetin | | acetamides; aromatic ether | cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pioglitazone | | aromatic ether; pyridines; thiazolidinediones | antidepressant; cardioprotective agent; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; geroprotector; hypoglycemic agent; insulin-sensitizing drug; PPARgamma agonist; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
piretanide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prazosin | | aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
primaquine | | aminoquinoline; aromatic ether; N-substituted diamine | antimalarial | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
proglumetacin | | aromatic ether; benzamides; carboxylic ester; monochlorobenzenes; N-acylindole; N-alkylpiperazine | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propoxur | | aromatic ether; carbamate ester | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrilamine | | aromatic ether; ethylenediamine derivative | H1-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulfadimethoxine | | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tetrahydropapaverine | | aromatic ether; benzylisoquinoline alkaloid; benzyltetrahydroisoquinoline; polyether; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tilorone | | aromatic ether; diether; fluoren-9-ones; tertiary amino compound | anti-inflammatory agent; antineoplastic agent; antiviral agent; interferon inducer; nicotinic acetylcholine receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ultram | | aromatic ether; tertiary alcohol; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triclosan | | aromatic ether; dichlorobenzene; monochlorobenzenes; phenols | antibacterial agent; antimalarial; drug allergen; EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; fungicide; persistent organic pollutant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
viloxazine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
wb 4101 | | aromatic ether; benzodioxine; secondary amino compound | alpha-adrenergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3',5-triiodothyropropionic acid | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methacetin | | acetamides; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mestranol | | 17beta-hydroxy steroid; aromatic ether; terminal acetylenic compound | prodrug; xenoestrogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
visnagin | | aromatic ether; furanochromone; polyketide | anti-inflammatory agent; antihypertensive agent; EC 1.1.1.37 (malate dehydrogenase) inhibitor; phytotoxin; plant metabolite; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-tert-butyl-4-hydroxyanisole | | aromatic ether; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mecoprop | | aromatic ether; monocarboxylic acid; monochlorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenetidine | | aromatic ether; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-4-chlorophenoxy gamma-butyric acid | | aromatic ether; monocarboxylic acid; monochlorobenzenes | environmental contaminant; phenoxy herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-bromophenyl phenyl ether | | aromatic ether; organobromine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
di-(4-aminophenyl)ether | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenyl ether | | aromatic ether | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diglycidyl resorcinol ether | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenetole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
scoparone | | aromatic ether; coumarins | anti-allergic agent; anti-inflammatory agent; antihypertensive agent; antilipemic drug; immunosuppressive agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimethoxyphenylethylamine | | alkaloid; aromatic ether; phenylethylamine | allergen; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dichlorprop | | aromatic ether; dichlorobenzene; monocarboxylic acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-tert-butyl-4-hydroxyanisole | | aromatic ether; phenols | antioxidant; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethyl vanillin | | aromatic ether; benzaldehydes; phenols | antioxidant; flavouring agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzethonium chloride | | aromatic ether; chloride salt; quaternary ammonium salt | antibacterial agent; antifungal agent; antiseptic drug; antiviral agent; disinfectant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
peucedanin | | aromatic ether; furanocoumarin; lactone | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenetidine | | aromatic ether; primary amino compound; substituted aniline | drug metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methoxybenzoxazolinone | | aromatic ether; benzoxazole | antibacterial agent; anticonvulsant; antifungal agent; muscle relaxant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-anisidine | | aromatic ether; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
domiphen bromide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dibrompropamidine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-Ethoxyphenol | | aromatic ether; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bulbocapnine | | aporphine alkaloid; aromatic ether; oxacycle; phenols | EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor; EC 1.4.3.22 (diamine oxidase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzydamine | | aromatic ether; indazoles; tertiary amino compound | analgesic; central nervous system stimulant; hallucinogen; local anaesthetic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xylocholine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-methoxycatechol | | aromatic ether; catechols | G-protein-coupled receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-phenoxypropanoic acid | | aromatic ether; carboxylic acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methoxyquinoline | | aromatic ether; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metaxalone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
heliamine | | aromatic ether; diether; isoquinoline alkaloid; isoquinolines | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4,6-trichlorophenyl 4-nitrophenyl ether | | aromatic ether; C-nitro compound; chlorobenzenes | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etridiazol | | aromatic ether; organochlorine compound; thiadiazole antifungal agent; thiadiazoles | antifungal agrochemical; nitrification inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
toliprolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxyindoleacetic acid | | aromatic ether; indole-3-acetic acids | antibacterial agent; Brassica napus metabolite; carcinogenic agent; human urinary metabolite; marine xenobiotic metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
iproclozide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenoxyacetic acid | | aromatic ether; monocarboxylic acid | allergen; Aspergillus metabolite; human xenobiotic metabolite; plant growth retardant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nafenopin | | aromatic ether; monocarboxylic acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl vanillate | | aromatic ether; benzoate ester; phenols | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxyindole-2-carboxylic acid | | aromatic ether; indolecarboxylic acid | EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor; hypoglycemic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-isopropoxyphenol | | aromatic ether; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dehydroemetine | | aromatic ether; isoquinolines; pyridoisoquinoline | antileishmanial agent; antimalarial; antiprotozoal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2-epoxy-3-(p-nitrophenoxy)propane | | aromatic ether; C-nitro compound; epoxide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
laurolitsine | | aporphine alkaloid; aromatic ether; phenols | HIV-1 integrase inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metocurine iodide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ac 45594 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-phenoxybenzylalcohol | | aromatic ether; benzyl alcohols | marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
devrinol | | aromatic ether; monocarboxylic acid amide; naphthalenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluorodifen | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acridine half-mustard | | aminoacridines; aromatic ether; organochlorine compound; secondary amino compound | mutagen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
precocene i | | aromatic ether; chromenes | plant metabolite; precocenes | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxadiazon | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lofexidine | | aromatic ether; carboxamidine; dichlorobenzene; imidazoles | alpha-adrenergic agonist; antihypertensive agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alclofenac | | aromatic ether; monocarboxylic acid; monochlorobenzenes | drug allergen; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylglycidyl ether | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenoxyethanol | | aromatic ether; glycol ether; primary alcohol | antiinfective agent; central nervous system depressant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metipranolol | | acetate ester; aromatic ether; propanolamine; secondary amino compound | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
silybin | | aromatic ether; benzodioxine; flavonolignan; polyphenol; secondary alpha-hydroxy ketone | antineoplastic agent; antioxidant; hepatoprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxamethacin | | aromatic ether; hydroxamic acid; N-acylindole; organochlorine compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
canadine | | aromatic ether; berberine alkaloid; organic heteropentacyclic compound; oxacycle | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-ethoxycoumarin | | aromatic ether; coumarins | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
medifoxamine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlormethoxynil | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
climbazole | | aromatic ether; hemiaminal ether; imidazoles; ketone; monochlorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hexyloxyaniline | | aromatic ether; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ticrynafen | | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid; thiophenes | antihypertensive agent; hepatotoxic agent; loop diuretic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-(2,4-dichlorophenoxy)phenoxy)propionic acid | | aromatic ether; dichlorobenzene; diether; monocarboxylic acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bezafibrate | | aromatic ether; monocarboxylic acid amide; monocarboxylic acid; monochlorobenzenes | antilipemic drug; environmental contaminant; geroprotector; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxyfluorofen | | aromatic ether | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triadimefon | | aromatic ether; hemiaminal ether; ketone; monochlorobenzenes; triazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
levobunolol | | aromatic ether; cyclic ketone; propanolamine | antiglaucoma drug; beta-adrenergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dichlorfop-methyl | | aromatic ether; dichlorobenzene; diether; methyl ester | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
decamethrin | | aromatic ether; cyclopropanecarboxylate ester; nitrile; organobromine compound | agrochemical; antifeedant; calcium channel agonist; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triadimenol | | aromatic ether; conazole fungicide; hemiaminal ether; monochlorobenzenes; secondary alcohol; triazole fungicide | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triclopyr | | aromatic ether; chloropyridine; monocarboxylic acid | agrochemical; environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prenalterol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
st 1059 | | aromatic ether; primary amino compound; secondary alcohol | alpha-adrenergic agonist; sympathomimetic agent; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
paroxetine | | aromatic ether; benzodioxoles; organofluorine compound; piperidines | antidepressant; anxiolytic drug; hepatotoxic agent; P450 inhibitor; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acifluorfen | | aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bopindolol | | aromatic ether; benzoate ester; methylindole; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenpropathrin, (+-)-isomer | | aromatic ether; cyclopropanecarboxylate ester | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triflumuron | | aromatic ether; benzoylurea insecticide; monochlorobenzenes; organofluorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flutolanil | | (trifluoromethyl)benzenes; aromatic ether; benzamides; benzanilide fungicide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenoxaprop ethyl | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triclabendazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acid | | aminopyridine; aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluvalinate | | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; nitrile; organochlorine acaricide; organochlorine insecticide; organofluorine acaricide; organofluorine insecticide | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
haloxyfop | | aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound; pyridines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluazifop-butyl | | aromatic ether; carboxylic ester; organofluorine compound; pyridines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fomesafen | | aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenoxycarb | | aromatic ether; carbamate ester | environmental contaminant; insecticide; juvenile hormone mimic; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quizalofop-ethyl | | aromatic ether; ethyl ester; organochlorine compound; quinoxaline derivative | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cetamolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
atomoxetine | | aromatic ether; secondary amino compound; toluenes | adrenergic uptake inhibitor; antidepressant; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl bensulfuron | | aromatic ether; methyl ester; N-sulfonylurea; pyrimidines | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
itraconazole | | aromatic ether; conazole antifungal drug; cyclic ketal; dichlorobenzene; dioxolane; N-arylpiperazine; triazole antifungal drug; triazoles | EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; Hedgehog signaling pathway inhibitor; P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
loxtidine | | aromatic ether; piperidines; primary alcohol; triazoles | H2-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
disoxaril | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chlorimuron ethyl | | aromatic ether; ethyl ester; N-sulfonylurea; organochlorine pesticide; pyrimidines; sulfamoylbenzoate | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; proherbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tepoxalin | | aromatic ether; hydroxamic acid; monochlorobenzenes; pyrazoles | antipyretic; apoptosis inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; immunomodulator; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
esmolol | | aromatic ether; ethanolamines; methyl ester; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pioglitazone hydrochloride | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aripiprazole | | aromatic ether; delta-lactam; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; quinolone | drug metabolite; H1-receptor antagonist; second generation antipsychotic; serotonergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sulfametrole | | aromatic ether; substituted aniline; sulfonamide antibiotic; thiadiazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propamidine | | aromatic ether; guanidines; polyether | antimicrobial agent; antiseptic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexamidine | | aromatic ether; guanidines; polyether | antimicrobial agent; antiseptic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
o-4-methylthymine | | aromatic ether; methylthymine | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenclofenac | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tetraiodothyroacetic acid | | 2-halophenol; aromatic ether; iodophenol; monocarboxylic acid | apoptosis inducer; human metabolite; thyroid hormone | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluazuron | | aromatic ether; chloropyridine; monochlorobenzenes; N-acylurea; organochlorine acaricide; organofluorine acaricide; phenylureas | acaricide; mite growth regulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etiroxate | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etofamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
d 888 | | aromatic ether; nitrile; tertiary amino compound | anti-arrhythmia drug; calcium channel blocker; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
esreboxetine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guaethol | | aromatic ether; phenols; volatile organic compound | flavouring agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spiramide | | aromatic ether; azaspiro compound; organofluorine compound; piperidines; tertiary amino compound | dopaminergic antagonist; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5'-nitro-2'-propoxyacetanilide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
suberosin | | aromatic ether; coumarins | anticoagulant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxyestradiol | | 17beta-hydroxy steroid; 3-hydroxy steroid; aromatic ether; phenols | estrogen; human metabolite; rat metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
toltrazuril | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
plafibride | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinitapride | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoscopoletin | | aromatic ether; hydroxycoumarin | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethofenprox | | aromatic ether | pyrethroid ether insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uk 68798 | | aromatic ether; sulfonamide; tertiary amino compound | anti-arrhythmia drug; potassium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hp 873 | | 1,2-benzoxazoles; aromatic ether; aromatic ketone; methyl ketone; monoamine; organofluorine compound; piperidines; tertiary amino compound | dopaminergic antagonist; second generation antipsychotic; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenoxypropazine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluphenacur | | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organofluorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amezinium | | aromatic ether; primary arylamine; pyridazinium ion | adrenergic uptake inhibitor; antihypotensive agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; sympathomimetic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rubrofusarin | | aromatic ether; benzochromenone; phenols; polyketide | biological pigment; EC 1.14.18.1 (tyrosinase) inhibitor; fungal metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triasulfuron | | 1,3,5-triazines; aromatic ether; N-sulfonylurea; organochlorine compound | agrochemical; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dauricine | | aromatic ether; bisbenzylisoquinoline alkaloid; isoquinolines; phenols; tertiary amino compound | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uvaretin | | aromatic ether; dihydrochalcones; polyketide; resorcinol | antineoplastic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fangchinoline | | aromatic ether; bisbenzylisoquinoline alkaloid; macrocycle | anti-HIV-1 agent; anti-inflammatory agent; antineoplastic agent; antioxidant; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prochloraz | | amide fungicide; aromatic ether; conazole fungicide; imidazole fungicide; imidazoles; trichlorobenzene; ureas | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stictic acid | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pramoxine hydrochloride | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-methoxybenzylamine | | aralkylamino compound; aromatic ether; primary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xanthurenic acid 8-methyl ether | | aromatic ether; monohydroxyquinoline; quinolinemonocarboxylic acid | carcinogenic agent; metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adriamycinol | | aminoglycoside; anthracycline antibiotic; aromatic ether; deoxy hexoside; p-quinones; phenols; polyol; tetracenequinones | cardiotoxic agent; drug metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
difenoconazole | | aromatic ether; conazole fungicide; cyclic ketal; dioxolane; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
a 8947 | | aromatic ether; biaryl; N-sulfonylurea; pyrazole pesticide; tetrazoles | EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thifluzamide | | 1,3-thiazoles; anilide fungicide; aromatic amide; aromatic ether; dibromobenzene; organofluorine compound | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethylhydrocupreine | | aromatic ether; cinchona alkaloid | EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-dihydromethysticin | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-dimethoxy-2-nitrobenzaldehyde | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bisphenol f diglycidyl ether | | aromatic ether; diarylmethane; epoxide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oryzemate | | 1,2-benzisothiazole; aromatic ether; benzothiazole fungicide; sulfone | antifungal agrochemical; plant activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bitertanol | | aromatic ether; biphenyls; secondary alcohol; triazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluazifop | | aromatic ether; monocarboxylic acid; organofluorine compound; pyridines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diflufenican | | (trifluoromethyl)benzenes; aromatic ether; pyridinecarboxamide | carotenoid biosynthesis inhibitor; environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexafluoron | | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organochlorine insecticide; organofluorine insecticide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diethofencarb | | aromatic ether; carbamate ester; carbanilate fungicide | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyriproxyfen | | aromatic ether; pyridines | juvenile hormone mimic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl 2-(((((4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)benzoate | | aromatic ether; benzoate ester; diamino-1,3,5-triazine; methyl ester; N-sulfonylurea | EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dpx e9636 | | aromatic ether; N-sulfonylurea; pyridines; pyrimidines; sulfone | environmental contaminant; herbicide; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aclonifen | | aromatic ether; C-nitro compound; monochlorobenzenes; primary amino compound; substituted aniline | agrochemical; carotenoid biosynthesis inhibitor; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinosulfuron | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clodinafop-propargyl | | aromatic ether; carboxylic ester; organochlorine compound; organofluorine compound; propyzamide; pyridines | agrochemical; EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
triflusulfuron-methyl | | 1,3,5-triazines; aromatic ether; benzoate ester; methyl ester; N-sulfonylurea; organofluorine compound; tertiary amino compound | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; proherbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vestitol | | aromatic ether; hydroxyisoflavans; methoxyisoflavan | anti-inflammatory agent; phytoalexin; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
laudanine | | aromatic ether; benzylisoquinoline alkaloid; benzyltetrahydroisoquinoline; phenols; racemate | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cryptopleurine | | alkaloid antibiotic; alkaloid; aromatic ether; organic heteropentacyclic compound | antineoplastic agent; antiviral agent; protein synthesis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-hydroxymethylmexiletine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxymexiletine | | aromatic ether; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cloquintocet-mexyl | | aromatic ether; carboxylic ester; organochlorine compound; quinolines | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
novaluron | | aromatic ether; benzoylurea insecticide; monochlorobenzenes; organofluorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bursehernin | | aromatic ether; benzodioxoles; butan-4-olide; lignan | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,2',4,4'-tetrabromodiphenyl ether | | aromatic ether; organobromine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
allocryptopine | | aromatic ether; cyclic acetal; cyclic ketone; dibenzazecine alkaloid; organic heterotetracyclic compound; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sporidesmin | | aromatic ether; cyclic ketone; diketone; organic disulfide; organic heteropentacyclic compound; organochlorine compound; secondary alcohol; tertiary alcohol; tertiary amino compound | mycotoxin; Wnt signalling activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
syringaresinol | | aromatic ether; furofuran; lignan; polyether; polyphenol | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
p-methoxy-n-methylphenethylamine | | aromatic ether; secondary amino compound | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aflatoxin q1 | | aflatoxin; aromatic ether; aromatic ketone | carcinogenic agent; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
u 73122 | | aromatic ether; aza-steroid; maleimides | EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyfluthrin | | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound | agrochemical; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norverapamil | | aromatic ether; nitrile; polyether; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fumitremorgin a | | aromatic ether; diol; indole alkaloid; organic heterohexacyclic compound; organic peroxide | mycotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deguelin | | aromatic ether; diether; organic heteropentacyclic compound; rotenones | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; mitochondrial NADH:ubiquinone reductase inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid ii | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tephrosin | | aromatic ether; cyclic ketone; organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; pesticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-hydroxymetoprolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(tetradecyloxy)-2-furancarboxylic acid | | aromatic ether; furoic acid | antineoplastic agent; apoptosis inducer; EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; PPARalpha agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tafenoquine | | (trifluoromethyl)benzenes; aminoquinoline; aromatic ether; primary amino compound; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxymethylomeprazole | | aromatic ether; benzimidazoles; pyridines; sulfoxide | drug metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ym 12617 | | aromatic ether; secondary amino compound; sulfonamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cgp 28392 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sodium-binding benzofuran isophthalate | | 1-benzofurans; aromatic ether; crown compound; tetracarboxylic acid | fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
garenoxacin | | aromatic ether; cyclopropanes; isoindoles; organofluorine compound; quinolinemonocarboxylic acid; quinolone antibiotic | antibacterial drug; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ay 25545 | | acetate ester; aromatic ether; C-glycosyl compound; naphthoisochromene; olefinic compound; phenols; tertiary amine | antimicrobial agent; antineoplastic agent; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
reboxetine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
b 823-08 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclazosin | | aromatic amide; aromatic ether; furans; monocarboxylic acid amide; quinazolines; quinoxaline derivative | adenosine A2A receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ivabradine | | aromatic ether; benzazepine; carbobicyclic compound; tertiary amino compound | cardiotonic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
febuxostat | | 1,3-thiazolemonocarboxylic acid; aromatic ether; nitrile | EC 1.17.3.2 (xanthine oxidase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
marsupsin | | 1-benzofurans; aromatic ether; polyphenol | antilipemic drug; hypoglycemic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6,6'-bieckol | | aromatic ether; oxacycle; phlorotannin | anti-HIV-1 agent; metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xibenolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cicloprolol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chs 828 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-methoxyphenoxy)propanoic acid | | aromatic ether; carboxylic acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
moxifloxacin | | aromatic ether; cyclopropanes; fluoroquinolone antibiotic; pyrrolidinopiperidine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | antibacterial drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rp 73401 | | aromatic ether; benzamides; chloropyridine; monocarboxylic acid amide | anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; phosphodiesterase IV inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,2',4,4',5,5'-hexabrominated diphenyl ether | | aromatic ether; organobromine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
varespladib | | aromatic ether; benzenes; dicarboxylic acid monoamide; indoles; monocarboxylic acid; primary carboxamide | anti-inflammatory drug; antidote; EC 3.1.1.4 (phospholipase A2) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
schizandrin b | | aromatic ether; cyclic acetal; organic heterotetracyclic compound; oxacycle; tannin | anti-asthmatic agent; anti-inflammatory agent; antilipemic drug; antioxidant; apoptosis inhibitor; hepatoprotective agent; nephroprotective agent; neuroprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s 23121 | | aromatic ether; dicarboximide; monochlorobenzenes; monofluorobenzenes; pyrroline; terminal acetylenic compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acrovestone | | acetophenones; aromatic ether; olefinic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
corytuberine | | aporphine alkaloid; aromatic ether; organic heterotetracyclic compound; polyphenol; tertiary amino compound | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
actinodaphine | | aporphine alkaloid; aromatic ether; organic heteropentacyclic compound; phenols; secondary amino compound | antibacterial agent; antifungal agent; antineoplastic agent; apoptosis inducer; plant metabolite; platelet aggregation inhibitor; topoisomerase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isohomovanillic acid | | aromatic ether; phenols; phenylacetic acids | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-diiodothyropropionic acid | | aromatic ether; monocarboxylic acid; organoiodine compound; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-dihydro-5,6-dehydrokawain | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-amino-2-methoxypyrimidine | | aminopyrimidine; aromatic ether; methylcytosine | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid D | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
myricanone | | aromatic ether; cyclic ketone; diarylheptanoid; methoxybenzenes; phenols | antineoplastic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pannarin | | aldehyde; aromatic ether; depsidones; organic heterotricyclic compound; organochlorine compound; phenols | antimicrobial agent; antineoplastic agent; apoptosis inducer; lichen metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminopotentidine | | aromatic ether; benzamides; guanidines; nitrile; piperidines; substituted aniline | H2-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aristolochic acid c | | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pluviatolide | | aromatic ether; benzodioxoles; butan-4-olide; lignan; phenols | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
erysodine | | aromatic ether; diether; Erythrina alkaloid; organic heterotetracyclic compound; phenols | antiparasitic agent; nicotinic antagonist; phytogenic insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
erlotinib | | aromatic ether; quinazolines; secondary amino compound; terminal acetylenic compound | antineoplastic agent; epidermal growth factor receptor antagonist; protein kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rubrofusarin B | | aromatic ether; benzochromenone; naphtho-gamma-pyrone; phenols; polyketide | Aspergillus metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ly 293111 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
enrasentan | | aromatic ether; benzodioxoles; indanes; monocarboxylic acid; monomethoxybenzene; primary alcohol | antihypertensive agent; endothelin receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quizalofop | | aromatic ether; monocarboxylic acid; organochlorine compound; quinoxaline derivative | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyhalofop-butyl | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyperin | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aflatoxin b1 | | aflatoxin; aromatic ether; aromatic ketone | carcinogenic agent; human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etravirine | | aminopyrimidine; aromatic ether; dinitrile; organobromine compound | antiviral agent; HIV-1 reverse transcriptase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-o-methyllicoricidin | | aromatic ether; hydroxyisoflavans; methoxyisoflavan | antibacterial agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pronuciferine | | aromatic ether; cyclic ketone; isoquinoline alkaloid; isoquinolines; organic heterotetracyclic compound | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dronedarone | | 1-benzofurans; aromatic ether; aromatic ketone; sulfonamide; tertiary amino compound | anti-arrhythmia drug; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
famoxadone | | aromatic ether; carbohydrazide; oxazolidinone | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cimicoxib | | aromatic ether; imidazoles; organochlorine compound; organofluorine compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sorafenib | | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; phenylureas; pyridinecarboxamide | angiogenesis inhibitor; anticoronaviral agent; antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; ferroptosis inducer; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dabuzalgron | | aromatic ether; imidazoles; monochlorobenzenes; sulfonamide | alpha-adrenergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fonsecin | | aromatic ether; cyclic hemiketal; heptaketide; naphtho-gamma-pyrone; phenols | Aspergillus metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lasofoxifene | | aromatic ether; N-alkylpyrrolidine; naphthols; tetralins | antineoplastic agent; bone density conservation agent; cardioprotective agent; estrogen receptor agonist; estrogen receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(+-)-Dihydromethysticin | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[2-[2-(2-aminophenoxy)ethoxy]ethoxy]aniline | | aromatic ether; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chondocurine (1beta)-(+-)-isomer | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methyl-4-prop-2-enoxy-2-pyrimidinone | | aromatic ether; pyrimidone | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
noscapine | | aromatic ether; benzylisoquinoline alkaloid; cyclic acetal; isobenzofuranone; organic heterobicyclic compound; organic heterotricyclic compound; tertiary amino compound | antineoplastic agent; antitussive; apoptosis inducer; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[4-(3-methyl-4-nitrophenoxy)butoxy]benzonitrile | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lariciresinol | | aromatic ether; lignan; oxolanes; phenols; primary alcohol | antifungal agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tryptoquivaline | | aromatic ether; indole alkaloid; organic heteropentacyclic compound | breast cancer resistance protein inhibitor; mycotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxyestrone | | 17-oxo steroid; 3-hydroxy steroid; alicyclic ketone; aromatic ether; phenolic steroid; phenols | human metabolite; mouse metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
win 54954 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
silychristin | | 1-benzofurans; aromatic ether; flavonolignan; polyphenol; secondary alpha-hydroxy ketone | lipoxygenase inhibitor; metabolite; prostaglandin antagonist; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cleomiscosin a | | aromatic ether; delta-lactone; organic heterotricyclic compound; phenols; primary alcohol | anti-inflammatory agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bispyribac | | aromatic ether; benzoic acids; monocarboxylic acid; pyrimidines | herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
petunidin-3-glucoside | | anthocyanin cation; aromatic ether; beta-D-glucoside | antioxidant; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
malvidin-3-glucoside | | anthocyanin cation; aromatic ether; beta-D-glucoside | metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dioncophylline c | | aromatic ether; biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes; naphthols | antimalarial; antiplasmodial drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
stigmatellin | | aromatic ether; chromones; olefinic compound; phenols | bacterial metabolite; quinol oxidation site inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
roflumilast | | aromatic ether; benzamides; chloropyridine; cyclopropanes; organofluorine compound | anti-asthmatic drug; phosphodiesterase IV inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
teniposide | | aromatic ether; beta-D-glucoside; cyclic acetal; furonaphthodioxole; gamma-lactone; monosaccharide derivative; phenols; thiophenes | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
prinomastat | | aromatic ether; hydroxamic acid; pyridines; sulfonamide; thiomorpholines | antineoplastic agent; EC 3.4.24.35 (gelatinase B) inhibitor; matrix metalloproteinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
posaconazole | | aromatic ether; conazole antifungal drug; N-arylpiperazine; organofluorine compound; oxolanes; triazole antifungal drug; triazoles | trypanocidal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gancaonin I | | 1-benzofurans; aromatic ether; resorcinols | antibacterial agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyrin | | aromatic ether; coumarins; hydroxyisoflavans | antibacterial agent; metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glyasperin D | | aromatic ether; hydroxyisoflavans; methoxyisoflavan | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
licoricidin | | aromatic ether; hydroxyisoflavans; methoxyisoflavan | antibacterial agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
egonol | | 1-benzofurans; aromatic ether; benzodioxoles; primary alcohol | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-ethylharmine | | aromatic ether; beta-carbolines; semisynthetic derivative | anti-HIV agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pf 1163a | | aromatic ether; lactam; macrolide antibiotic; secondary alcohol | antifungal agent; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pf 1163b | | aromatic ether; lactam; macrolide antibiotic | antifungal agent; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
licocoumarone | | 1-benzofurans; aromatic ether; resorcinols | antibacterial agent; apoptosis inducer; EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(4-chloro-2-methylphenoxy)-n-hydroxybutanamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
LSM-22807 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
piperlactam s | | alkaloid; aromatic ether; gamma-lactam; organic heterotetracyclic compound; phenols | anti-inflammatory agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,5-dioxo-1-(4-phenoxyphenyl)-3a,4,6,6a-tetrahydro-3H-thieno[3,4-b]pyrrol-2-one | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
antofine | | alkaloid antibiotic; alkaloid; aromatic ether; organic heteropentacyclic compound | angiogenesis inhibitor; anti-inflammatory agent; antimicrobial agent; antineoplastic agent; antiviral agent; phytotoxin; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xanthohumol | | aromatic ether; chalcones; polyphenol | anti-HIV-1 agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-phenoxy-N-(2-pyridinyl)butanamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-amino-4-(2-ethoxyphenyl)-3-propyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | | aromatic ether; pyranopyrazole | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[4-[[1-oxo-2-(1-pyrrolidinyl)ethyl]amino]phenoxy]phenyl]-2-(1-pyrrolidinyl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3,4-diethoxyphenyl)-5-(2-furanyl)-1,3,4-oxadiazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(phenoxymethyl)-4-(2-phenylethyl)-1,2,4-triazol-3-yl]thio]acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(8-methyl-2,5,11,14-tetraoxa-8-azabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)ethanol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[2-(3-phenoxypropyl)-5-tetrazolyl]pyridine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-cyclohexyl-5-(2-phenoxyethylthio)tetrazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[[5-[(3-methylphenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-amino-4-[3-ethoxy-4-[2-(4-morpholinyl)ethoxy]phenyl]-3-ethyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | | aromatic ether; pyranopyrazole | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-[(2,3-dimethylphenoxy)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-1-thiophen-2-ylethanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(1-methyl-2-imidazolyl)-(4-phenylmethoxyphenyl)methanol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(3-butoxyphenyl)-1,3,4-thiadiazol-2-amine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(2-ethoxy-6-methyl-3-pyridinyl)-5-(2-pyridinyl)-1,2,4-oxadiazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-(3,4,5-triethoxyphenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole | | aromatic ether; triazolothiadiazole | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(1-benzotriazolyl)-5-(2-methoxyphenoxy)benzene-1,2-dicarbonitrile | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-ethoxy-9-nitro-5H-benzo[b][1,4]benzoxazepin-6-one | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[4-(2-quinoxalinyl)phenoxy]benzene-1,2-dicarbonitrile | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-(phenoxymethyl)-4-triazolecarboxylic acid ethyl ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-ethylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(4-ethylphenoxy)methyl]-N-(2-pyridinylmethyl)-2-furancarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-methoxy-3,5-dimethyl-2-thiazolo[4,5-d]pyrimidinethione | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(4-ethylphenyl)-2-thiazolyl]carbamic acid phenyl ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-bromo-4-methylphenoxy)-N-(2-pyridinylmethyl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[[3-(4-chlorophenoxy)phenyl]methyl]-4-ethylpiperazine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[4-(ethylamino)-6-(methylthio)-1,3,5-triazin-2-yl]oxy]benzoic acid ethyl ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-ethyl-3-[[4-(2-methylpropoxy)phenyl]methylthio]-1H-1,2,4-triazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
[4-[(2-fluorophenyl)methoxy]phenyl]-(1-pyrrolidinyl)methanethione | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(2-chlorophenoxy)methyl]-3-pyridin-4-yl-1,2,4-oxadiazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(4-phenylmethoxyphenyl)thiadiazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(4-morpholinyl)ethanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(3-pyridinyloxy)benzene-1,2-dicarbonitrile | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-tert-butyl-2-(4-chloro-3-methylphenoxy)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-furanylmethyl)-3-(4-phenoxyphenyl)thiourea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-methylpropyl)-3-(4-phenoxyphenyl)thiourea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-cyclopentyl-3-(4-phenoxyphenyl)thiourea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(4-ethoxyphenoxy)methyl]-N-(3-pyridinyl)-2-furancarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(2-chlorophenoxy)methyl]-N-(2-thiazolyl)-2-furancarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4,5-dihydrothiazol-2-yl)-2-(2-methylphenoxy)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(2-fluorophenoxy)-1-methyl-3-nitro-1,2,4-triazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-methyl-5-(1-naphthalenyloxy)-4-nitroimidazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
curcumin | | aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3,4-dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-cyclopentyl-3-(2-phenoxyphenyl)thiourea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1-ethyl-2-benzimidazolyl)-5-[(4-methyl-2-nitrophenoxy)methyl]-2-furancarboxamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-12-(4-methoxyphenyl)sulfonylquinoxalino[2,3-b][1,4]benzoxazine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3-methoxy-5-nitrophenyl)-3-(4-methylphenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-bromo-4-chlorophenoxy)-N-cyclohexyl-N-methylacetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-furanyl-[4-(4-phenoxyphenyl)sulfonyl-1-piperazinyl]methanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(2-methoxyphenoxy)-N-(3-pyridinyl)benzenesulfonamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3-chlorophenyl)-3-(2-phenoxyphenyl)thiourea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[2-(1-azepanyl)-4,5-dicyanophenoxy]phenyl]acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[4-(dimethylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]oxy]benzoic acid methyl ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-5-methyl-3-phenyl-4-isoxazolecarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[4-[[4-(2-chloro-6-nitrophenoxy)phenyl]methoxy]phenyl]ethanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-[[2-(4-hydroxyphenyl)-1,3-dioxo-5-isoindolyl]oxy]phenyl]-2,2-dimethylpropanamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[[4-(4-chlorophenoxy)anilino]-sulfanylidenemethyl]benzamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-fluorophenoxy)-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]-N-propan-2-ylbenzenesulfonamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(4-tert-butylphenoxy)-5-methoxy-2-phenylpyrimidine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-phenoxy-2-phenyl-5-pyrimidinecarboxylic acid ethyl ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Src Inhibitor-1 | | aromatic ether; polyether; quinazolines; secondary amino compound | EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2,5-dioxo-6-(4-phenoxyphenyl)-3-pyrano[3,2-c]pyridinyl]benzamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-chlorophenoxy)-4-(dimethylamino)-3-pyridinecarbonitrile | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methyl-5-[2-(2-methylphenoxy)ethyl]-2-sulfanylidene-1H-pyrimidin-4-one | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N4-ethyl-6-[2-(4-methylphenoxy)ethylthio]-N2-propan-2-yl-1,3,5-triazine-2,4-diamine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(phenylmethyl)-3-[2-(4-propoxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[[1-oxo-3-(4-propan-2-yloxyphenyl)propyl]amino]-3-(phenylmethyl)thiourea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-(3-methylphenoxy)-5-nitrophenyl]-2-(3-nitro-1,2,4-triazol-1-yl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-bis(2-fluorophenoxy)phosphoryl-3,4-dimethylaniline | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-(2-ethoxyanilino)-6-(4-ethoxyanilino)-2-pyrimidinyl]methylidene]propanedinitrile | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-3-[(4-pentoxyphenyl)methylthio]-1H-1,2,4-triazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4,5-dichloro-1-[2-(4-chlorophenoxy)ethyl]imidazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-butyl-3-(4-phenoxyphenyl)thiourea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-cyano-2-thiophenyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-bromophenyl)-5-[(2-chlorophenoxy)methyl]-1,3,4-oxadiazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-ethoxyphenyl)-N-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1,3,4-oxadiazol-2-amine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(4-chloro-2-methylphenoxy)-1-(4-morpholinyl)-1-butanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N9-(4-butoxyphenyl)-6,8,10-triazaspiro[4.5]deca-6,9-diene-7,9-diamine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[2-(4-chlorophenoxy)ethylthio]pyrimidine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(3-phenoxypropyl)-3-(3-pyridinyl)-1,2,4-oxadiazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(3-ethoxy-2-prop-2-enoxyphenyl)methyl]-2-thiazolamine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-bromophenoxy)-N-(2-pyridinylmethyl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[2-[(4-chlorophenyl)thio]ethoxy]-3-ethoxybenzaldehyde | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3-fluorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-4H-pyridine-3,5-dicarboxylic acid diethyl ester | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(2-ethoxyphenyl)-3H-1,3,4-oxadiazole-2-thione | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-tert-butyl-4-(2-fluorophenoxy)-1-butanamine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-butyl-4-phenoxy-1-butanamine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[3-[[diethylamino(sulfanylidene)methyl]thio]-1-oxopropyl]carbamic acid (4-methylphenyl) ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,3-dimethyl-5-[[2-[2-(4-nitrophenoxy)ethoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trione | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[2-(3-ethylphenoxy)ethyl]propanedioic acid diethyl ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,3-dihydro-1,4-dioxin-5-carboxylic acid [2-[4-[4-(2-methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl] ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[3-(2-bromo-4-chlorophenoxy)propyl]-4-methylpiperidine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N4-(2-methoxyphenyl)benzene-1,4-diamine | | aromatic ether; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(1H-benzimidazol-2-ylthio)butanoic acid [2-oxo-2-(4-phenoxyanilino)ethyl] ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-phenoxybenzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[2,5-dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[6-amino-1-(2-methylpropyl)-2,4-dioxo-5-pyrimidinyl]-2-(2-methylphenoxy)-N-(2-methylpropyl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[[6-[(2-methyl-5-thieno[2,3-e][1,3]benzothiazolyl)oxy]-3-pyridinyl]sulfonyl]morpholine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(3-fluorophenoxy)-8-nitroisoquinoline | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[4-(2-prop-2-enylphenoxy)butyl]pyrrolidine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2,4-dibromophenoxy)-N-[oxo-(propan-2-ylamino)methyl]acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-phenoxyphenyl 4-hydroxypiperidine-1-carboxylate | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-benzoyl-5-(3,5-dichlorophenoxy)-2-furancarbohydrazide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[2-[(4-chlorophenoxy)methyl]-4-thiazolyl]ethanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(benzyloxy)-2-(hydroxymethyl)-1,4-dihydropyridin-4-one | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-aminophenoxy)isophthalonitrile | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N5-(2-chloro-6-phenoxybenzyl)-1H-1,2,4-triazole-3,5-diamine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2-chloro-6-phenoxyphenyl)methyl]benzenesulfonamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-(tert-butyl)-3-isoxazolyl]-N'-[2-(trifluoromethoxy)phenyl]urea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-(4-methoxyphenoxy)-2-imidazo[1,2-b]pyridazinecarboxylic acid ethyl ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrile | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,4-dichloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-anilino-3-[4-(3-anilino-2-hydroxypropoxy)phenoxy]-2-propanol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[4-(3-ethoxyphenoxy)butyl]imidazole | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-oxolanecarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[[2-(2,4-difluorophenoxy)-1-oxopropyl]amino]-3-(2-oxolanylmethyl)thiourea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[[(5-bromo-6-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-2-(2-chlorophenoxy)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-oxido-3-(4-phenoxyphenyl)-4a,5,6,7,8,8a-hexahydroquinoxalin-1-ium 1-oxide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(2-fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[5-[(2-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclopropanecarboxylic acid [2-oxo-2-(4-phenoxyanilino)ethyl] ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
toremifene | | aromatic ether; organochlorine compound; tertiary amine | antineoplastic agent; bone density conservation agent; estrogen antagonist; estrogen receptor modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dieckol | | aromatic ether; oxacycle; phlorotannin | anticoagulant; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; metabolite; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naproxol | | aromatic ether | antipyretic; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tamoxifen n-oxide | | aromatic ether; tertiary amine oxide | anti-estrogen; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diafenthiuron | | aromatic ether; thiourea acaricide; thiourea insecticide | oxidative phosphorylation inhibitor; proinsecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ospemifene | | aromatic ether; organochlorine compound; primary alcohol | anti-inflammatory agent; antineoplastic agent; estrogen receptor modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tandutinib | | aromatic ether; N-arylpiperazine; N-carbamoylpiperazine; phenylureas; piperidines; quinazolines; tertiary amino compound | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zd 6474 | | aromatic ether; organobromine compound; organofluorine compound; piperidines; quinazolines; secondary amine | antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
adefovir | | aromatic ether; aromatic ketone; biaryl; cyclic ketone; naphtho-gamma-pyrone; organooxygen heterocyclic antibiotic; polyphenol | antimalarial; Aspergillus metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-chloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-hydroxyethyl)-4-[2-nitro-4-(trifluoromethyl)phenoxy]benzamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N'-[2-[(4-amino-5-cyano-2-pyrimidinyl)thio]-1-oxoethyl]-2-(4-methylphenoxy)acetohydrazide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2-methyl-4-thiazolyl)methyl]-4-phenoxybenzenesulfonamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-amino-4-(2-ethoxy-4-hydroxyphenyl)-3-propyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | | aromatic ether; pyranopyrazole | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[(2-ethoxyphenyl)methyl]-3-thiophen-2-ylurea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quinoxyfen | | aromatic ether; monofluorobenzenes; organochlorine compound; quinolines | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nafadotride | | aromatic ether; naphthalenecarboxamide; nitrile; pyrrolidines; tertiary amino compound | dopaminergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(1-naphthalenyl)-3-[[2-(2-nitrophenoxy)-1-oxoethyl]amino]urea | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methyl-1,3-bis(phenylmethoxy)benzene | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[(4-ethylphenoxy)methyl]-4-(6-methylheptan-2-yl)-1H-1,2,4-triazole-5-thione | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-chloro-N-(2-methyl-6-oxo-5H-benzo[b][1,4]benzoxazepin-8-yl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(benzenesulfonyl)-4-(2,6-dimethylphenoxy)-2-phenylpyrimidine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(2-methylphenoxy)-6-phenylfuro[2,3-d]pyrimidine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[4-(2-chlorophenoxy)butyl]imidazole | | aromatic ether; imidazoles; monochlorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-chlorophenyl)-4-[[(2-methoxy-4-nitroanilino)-sulfanylidenemethyl]hydrazo]-4-oxobutanamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(2-methoxy-4-nitrophenyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide | | aromatic ether; C-nitro compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[4-(phenoxymethyl)-2-thiazolyl]-1-adamantanecarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxypioglitazone | | aromatic ether; pyridines; thiazolidinediones | human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sc 560 | | aromatic ether; monochlorobenzenes; organofluorine compound; pyrazoles | angiogenesis modulating agent; antineoplastic agent; apoptosis inducer; cyclooxygenase 1 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sc-19220 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methyl-4-(3-phenoxyphenyl)-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-6-carboxylic acid ethyl ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-[4-(4-fluorophenoxy)-3-nitrophenyl]-7-(2-hydroxyethyl)-3-(phenylmethyl)purine-2,6-dione | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-phenoxybenzoic acid [2-oxo-2-(propan-2-ylamino)ethyl] ester | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-bromophenoxy)-N'-[2-[(4-methyl-1,2,4-triazol-3-yl)thio]-1-oxoethyl]acetohydrazide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(2-methoxyanilino)-2-(2-phenylmethoxyphenyl)acetonitrile | | aromatic ether; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(4-phenoxyphenyl)-2-(1,2,3,4-tetrahydroisoquinolin-1-yl)acetamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(3,4-dimethoxyphenyl)-3-(2-furanylmethyl)-4-imino-5H-[1]benzopyrano[2,3-d]pyrimidin-8-ol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,3-dimethyl-1,5-dinitro-6-phenoxy-3-azoniabicyclo[3.3.1]non-6-ene | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fraxin | | aromatic ether; beta-D-glucoside; hydroxycoumarin | anti-inflammatory agent; hepatoprotective agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fraxetin | | aromatic ether; hydroxycoumarin | anti-inflammatory agent; antibacterial agent; antimicrobial agent; antioxidant; apoptosis inducer; apoptosis inhibitor; Arabidopsis thaliana metabolite; hepatoprotective agent; hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,6-dehydrokawain | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
jtk-303 | | aromatic ether; monochlorobenzenes; organofluorine compound; quinolinemonocarboxylic acid; quinolone | HIV-1 integrase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
coniferin | | aromatic ether; cinnamyl alcohol beta-D-glucoside; monosaccharide derivative | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
daphnoretin | | aromatic ether; hydroxycoumarin | antineoplastic agent; antiviral agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kavain | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methysticin | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
yangonin | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hinokiflavone | | aromatic ether; biflavonoid; hydroxyflavone | antineoplastic agent; metabolite; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gentiacaulein | | aromatic ether; polyphenol; xanthones | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gentisin | | aromatic ether; polyphenol; xanthones | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isogentisin | | aromatic ether; polyphenol; xanthones | EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mangostin | | aromatic ether; phenols; xanthones | antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,8-dihydroxy-3,7-dimethoxyxanthone | | aromatic ether; polyphenol; xanthones | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
swerchirin | | aromatic ether; phenols; xanthones | hypoglycemic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,2,8-trihydroxy-6-methoxyxanthone | | aromatic ether; polyphenol; xanthones | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
wedelolactone | | aromatic ether; coumestans; delta-lactone; polyphenol | antineoplastic agent; apoptosis inducer; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; hepatoprotective agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyhalothrin | | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sofalcone | | aromatic ether; chalcones; monocarboxylic acid | anti-ulcer drug; antibacterial agent; gastrointestinal drug; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neticonazole | | aromatic ether; benzenes; conazole antifungal drug; enamine; imidazole antifungal drug; imidazoles; methyl sulfide | antifungal drug; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pibutidine | | aromatic ether; cyclobutenones; olefinic compound; piperidines; primary amino compound; pyridines; secondary amino compound | anti-ulcer drug; H2-receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-(2-chlorophenyl)-3-(4-ethoxyphenyl)-6-oxo-2,4,7,8-tetrahydropyrido[2,1-b][1,3,5]thiadiazine-9-carbonitrile | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro 41-5253 | | aromatic ether; benzoic acids; sulfone; thiochromane | apoptosis inducer; retinoic acid receptor alpha antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycycoumarin | | aromatic ether; coumarins; resorcinols | antispasmodic drug; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoginkgetin | | aromatic ether; biflavonoid | antineoplastic agent; EC 3.4.24.35 (gelatinase B) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neoglycyrol | | aromatic ether; coumestans; delta-lactone; polyphenol | antineoplastic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rhamnazin | | aromatic ether; dimethoxyflavone; phenols; trihydroxyflavone | antineoplastic agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bosutinib | | aminoquinoline; aromatic ether; dichlorobenzene; N-methylpiperazine; nitrile; tertiary amino compound | antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bw b70c | | aromatic ether; hydroxamic acid; organofluorine compound; ureas | EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lichexanthone | | aromatic ether; phenols; xanthones | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alternariol monomethyl ether | | aromatic ether; benzochromenone | antifungal agent; fungal metabolite; mycotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
decussatin | | aromatic ether; phenols; xanthones | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bedaquiline | | aromatic ether; naphthalenes; organobromine compound; quinolines; tertiary alcohol; tertiary amino compound | antitubercular agent; ATP synthase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dimethomorph | | aromatic ether; enamide; monochlorobenzenes; morpholine fungicide; tertiary carboxamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benanomicin b | | aromatic ether; disaccharide derivative; L-alanine derivative; polyketide; polyphenol; pradimicin; secondary alcohol | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pradimicin b | | aromatic ether; L-alanine derivative; monosaccharide derivative; polyketide; polyphenol; pradimicin; secondary alcohol | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1,7-dihydroxy-4-methoxyxanthone | | aromatic ether; phenols; xanthones | metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pradimicin a | | aromatic ether; carboxylic acid; disaccharide derivative; L-alanine derivative; p-quinones; polyphenol; pradimicin; secondary alcohol | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clodinafop | | aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound; pyridines | EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; phenoxy herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ici 118551 | | aromatic ether; indanes; secondary alcohol; secondary amino compound | beta-adrenergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ochnaflavone | | aromatic ether; biflavonoid; hydroxyflavone | anti-inflammatory agent; antiatherogenic agent; antibacterial agent; EC 3.1.1.4 (phospholipase A2) inhibitor; leukotriene antagonist; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(4-fluorophenoxy)-6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene 1-oxide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flavasperone | | aromatic ether; naphtho-gamma-pyrone; phenols | acyl-CoA:cholesterol acyltransferase 2 inhibitor; antiviral agent; Aspergillus metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxycordoin | | aromatic ether; chalcones; polyphenol | anti-inflammatory agent; antibacterial agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-feruloylserotonin | | aromatic ether; cinnamamides; hydroxyindoles; phenols; secondary carboxamide | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tyrphostin ag825 | | aromatic ether; benzothiazoles; enamide; nitrile; organic sulfide; phenols; primary carboxamide | epidermal growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kresoxim-methyl | | aromatic ether; methoxyiminoacetate strobilurin antifungal agent; methyl ester; oxime O-ether | antifungal agrochemical; environmental contaminant; mitochondrial cytochrome-bc1 complex inhibitor; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-methoxy-3,6-diphenyl-1,2,4-triazine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrachlostrobin | | aromatic ether; carbamate ester; carbanilate fungicide; methoxycarbanilate strobilurin antifungal agent; monochlorobenzenes; pyrazoles | antifungal agrochemical; environmental contaminant; mitochondrial cytochrome-bc1 complex inhibitor; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
piericidin a | | aromatic ether; methylpyridines; monohydroxypyridine; secondary allylic alcohol | antimicrobial agent; bacterial metabolite; EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor; mitochondrial respiratory-chain inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metrafenone | | aromatic ether; aryl phenyl ketone fungicide; benzophenones; organobromine compound | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(4-fluoro-3-(trifluoromethyl)phenoxy)-n-(phenylmethyl)butanamide | | (trifluoromethyl)benzenes; aromatic ether; monocarboxylic acid amide; monofluorobenzenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
b 43 | | aromatic amine; aromatic ether; cyclopentanes; primary amino compound; pyrrolopyrimidine | EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-(4-phenylbutoxy)psoralen | | aromatic ether; benzenes; psoralens | geroprotector; immunosuppressive agent; potassium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-ia-85380 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
yunaconitine | | acetate ester; aromatic ether; benzoate ester; bridged compound; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary alcohol; tertiary amino compound | antifeedant; human urinary metabolite; phytotoxin; plant metabolite; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ru 58668 | | 17beta-hydroxy steroid; 3-hydroxy steroid; aromatic ether; organofluorine compound; sulfone | anti-estrogen; antineoplastic agent; estrogen receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
altenusin | | aromatic ether; carboxybiphenyl; catechols; hydroxybiphenyls; polyphenol | antifungal agent; fungal metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gw 501516 | | 1,3-thiazoles; aromatic ether; aryl sulfide; monocarboxylic acid; organofluorine compound | carcinogenic agent; PPARbeta/delta agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bay 58-2667 | | aromatic ether; benzoic acids; dicarboxylic acid; tertiary amino compound | antihypertensive agent; soluble guanylate cyclase activator; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
camostat | | aromatic ether; phenols | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lenvatinib | | aromatic amide; aromatic ether; cyclopropanes; monocarboxylic acid amide; monochlorobenzenes; phenylureas; quinolines | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist; orphan drug; vascular endothelial growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nsc 716970 | | aromatic amine; aromatic ether; indolecarboxamide; organochlorine compound | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lobeglitazone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
noviflumuron | | aromatic ether; benzoylurea insecticide; dichlorobenzene; organofluorine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
etomoxir | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fr 148083 | | aromatic ether; macrolide; phenols; secondary alcohol; secondary alpha-hydroxy ketone | antibacterial agent; antineoplastic agent; metabolite; NF-kappaB inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
9-methoxycanthin-6-one | | aromatic ether; indole alkaloid; organic heterotetracyclic compound | antineoplastic agent; antiplasmodial drug; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sb 3ct compound | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
varespladib methyl | | aromatic ether; benzenes; indoles; methyl ester; primary carboxamide | anti-inflammatory drug; antidote; EC 3.1.1.4 (phospholipase A2) inhibitor; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dapagliflozin | | aromatic ether; C-glycosyl compound; monochlorobenzenes | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naveglitazar | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tivozanib | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ustiloxin b | | aromatic ether; heterodetic cyclic peptide; macrocycle; phenols; secondary alcohol; secondary carboxamide; sulfoxide | Aspergillus metabolite; microtubule-destabilising agent; mycotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hypothemycin | | aromatic ether; diol; enone; epoxide; macrolide; phenols; polyketide; secondary alpha-hydroxy ketone | antifungal agent; antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; fungal metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tryprostatin a | | aromatic ether; dipeptide; indole alkaloid; indoles; pyrrolopyrazine | breast cancer resistance protein inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cediranib | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-iodothyronamine | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride | | aromatic ether; hydrochloride; methoxybenzenes; tertiary amino compound | antipsychotic agent; receptor modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rubraxanthone | | aromatic ether; polyphenol; xanthones | antibacterial agent; antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7,8-Dihydroyangonin | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sch 51344 | | aromatic amine; aromatic ether; primary alcohol; pyrazoloquinoline; secondary amino compound | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ancistroealaine a | | aromatic ether; biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes | antileishmanial agent; antiplasmodial drug; metabolite; trypanocidal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pimavanserin | | aromatic ether; monofluorobenzenes; piperidines; tertiary amino compound; ureas | 5-hydroxytryptamine 2A receptor inverse agonist; antipsychotic agent; serotonergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tolfenpyrad | | aromatic amide; aromatic ether; organochlorine compound; pyrazole insecticide | agrochemical; antifungal agent; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mitochondrial NADH:ubiquinone reductase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
SIS3 free base | | aromatic ether; enamide; isoquinolines; monocarboxylic acid amide; pyrrolopyridine; tertiary carboxamide | Smad3 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
apixaban | | aromatic ether; lactam; piperidones; pyrazolopyridine | anticoagulant; EC 3.4.21.6 (coagulation factor Xa) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bibw 2992 | | aromatic ether; enamide; furans; monochlorobenzenes; organofluorine compound; quinazolines; secondary carboxamide; tertiary amino compound | antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydrokavain | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
troglitazone sulfate | | aromatic ether; thiazolidinone | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
arisugacin | | aromatic ether; delta-lactone; enone; organic heterotetracyclic compound; tertiary alcohol | antimicrobial agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite; Penicillium metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
saracatinib | | aromatic ether; benzodioxoles; diether; N-methylpiperazine; organochlorine compound; oxanes; quinazolines; secondary amino compound | anticoronaviral agent; antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; radiosensitizing agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fonsecinone a | | aromatic ether; aromatic ketone; biaryl; cyclic ketone; naphtho-gamma-pyrone; polyphenol | antibacterial agent; Aspergillus metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
crenolanib | | aminopiperidine; aromatic ether; benzimidazoles; oxetanes; quinolines; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aiphanol | | aromatic ether; benzodioxine; lignan; stilbenoid | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nigerloxin | | aromatic ether; benzamides; benzoic acids; phenols; styrenes | antioxidant; Aspergillus metabolite; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
msdc-0160 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dihydroxanthohumol | | aromatic ether; dihydrochalcones; polyphenol | EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
PB28 | | aromatic ether; piperazines; tetralins | anticoronaviral agent; antineoplastic agent; apoptosis inducer; sigma-2 receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-phloroeckol | | aromatic ether; phlorotannin | antioxidant; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-beta-D-glucopyranoside | | aromatic ether; benzyl alcohols; beta-D-glucoside; monosaccharide derivative; primary alcohol | antineoplastic agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
PDGF receptor tyrosine kinase inhibitor III | | aromatic ether; N-arylpiperazine; N-carbamoylpiperazine; phenylureas; quinazolines; tertiary amino compound | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluoxastrobin | | aromatic ether; dioxazine; monochlorobenzenes; organofluorine compound; oxime O-ether; pyrimidines; strobilurin antifungal agent | antifungal agrochemical; mitochondrial cytochrome-bc1 complex inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
regorafenib | | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; monofluorobenzenes; phenylureas; pyridinecarboxamide | antineoplastic agent; hepatotoxic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
erastin | | aromatic ether; diether; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; quinazolines; tertiary carboxamide | antineoplastic agent; ferroptosis inducer; voltage-dependent anion channel inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
brivanib | | aromatic ether; diether; fluoroindole; pyrrolotriazine; secondary alcohol | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; drug metabolite; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fg-4592 | | aromatic ether; isoquinolines; N-acylglycine | EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
picoxystrobin | | aromatic ether; enoate ester; enol ether; methoxyacrylate strobilurin antifungal agent; organofluorine compound; pyridines | antifungal agrochemical; mitochondrial cytochrome-bc1 complex inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cenicriviroc | | aromatic ether; benzazocine; diether; imidazoles; secondary carboxamide; sulfoxide | anti-HIV agent; anti-inflammatory agent; antirheumatic drug; chemokine receptor 2 antagonist; chemokine receptor 5 antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mandipropamid | | aromatic ether; monocarboxylic acid amide; monochlorobenzenes; terminal acetylenic compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glyceryl ferulate | | 1-monoglyceride; aromatic ether; enoate ester; phenols | antioxidant; plant metabolite; ultraviolet filter | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ki 8751 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ceratamine a | | alkaloid; aromatic ether; cyclic ketone; organic heterobicyclic compound; organobromine compound; secondary amino compound; tertiary amine | antimitotic; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azd 8931 | | aromatic ether; monochlorobenzenes; monofluorobenzenes; piperidines; quinazolines; secondary amino compound; tertiary amino compound | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bay94 9172 | | (18)F radiopharmaceutical; aromatic ether; polyether; secondary amino compound; stilbenoid; substituted aniline | radioactive imaging agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
olodaterol | | aromatic ether; benzoxazine; phenols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dorsomorphin | | aromatic ether; piperidines; pyrazolopyrimidine; pyridines | bone morphogenetic protein receptor antagonist; EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cj-042794 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hu 308 | | aromatic ether; bridged compound; carbobicyclic compound; primary allylic alcohol; synthetic cannabinoid | anti-inflammatory agent; antihypertensive agent; apoptosis inhibitor; bone density conservation agent; CB2 receptor agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ki11502 | | aromatic ether; benzamides; quinolines; thioureas | antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
apremilast | | aromatic ether; N-acetylarylamine; phthalimides; sulfone | non-steroidal anti-inflammatory drug; phosphodiesterase IV inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
PF-00835231 | | aromatic ether; indolecarboxamide; L-leucine derivative; primary alcohol; pyrrolidin-2-ones; secondary carboxamide | anticoronaviral agent; drug metabolite; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine | | aminopyridine; aromatic ether; dichlorobenzene; organofluorine compound; pyrazolylpiperidine; racemate | antineoplastic agent; biomarker; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chir-265 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aminocandin | | aromatic ether; echinocandin; homodetic cyclic peptide | antiinfective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zk 756326 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bay 60-6583 | | aminopyridine; aromatic ether; aryl sulfide; cyanopyridine; cyclopropanes; monocarboxylic acid amide | adenosine A2B receptor agonist; anti-inflammatory agent; cardioprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
empagliflozin | | aromatic ether; C-glycosyl compound; monochlorobenzenes; tetrahydrofuryl ether | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-[5-(4-ethoxyphenyl)-3-isoxazolyl]-N-[(4-methylphenyl)methyl]butanamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bgt226 | | aromatic ether; imidazoquinoline; N-arylpiperazine; organofluorine compound; pyridines | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-desmethylrosiglitazone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(5-methyl-3-nitro-1-pyrazolyl)-N-[3-(4-methylphenoxy)-5-nitrophenyl]butanamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
verruculogen | | aromatic ether; diol; indole alkaloid; organic heterohexacyclic compound; organic peroxide | Aspergillus metabolite; GABA modulator; mycotoxin; Penicillium metabolite; potassium channel blocker | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-O-feruloyl-beta-D-glucose | | aromatic ether; beta-D-glucoside; cinnamate ester; phenols | antioxidant; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2,2',4,5'-tetrabromodiphenyl ether | | aromatic ether; organobromine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hexabromodiphenyl ether 154 | | aromatic ether; organobromine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bde 183 | | aromatic ether; organobromine compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
l-798106 | | aromatic ether; bromobenzenes; N-sulfonylcarboxamide | prostaglandin receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aflatoxin m1 | | aflatoxin; aromatic ether; aromatic ketone; tertiary alcohol | Aspergillus metabolite; human xenobiotic metabolite; mammalian metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
macitentan | | aromatic ether; organobromine compound; pyrimidines; ring assembly; sulfamides | antihypertensive agent; endothelin receptor antagonist; orphan drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
CDN1163 | | aromatic ether; quinolines; secondary carboxamide | SERCA activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
e 7050 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(5-chloro-2-thiophenyl)methyl]-5-[(2,6-difluorophenoxy)methyl]-3-isoxazolecarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dafadine C | | aromatic amide; aromatic ether; difluorobenzene; isoxazoles; N-acylpiperidine; pyridines | P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dafadine B | | aromatic amide; aromatic ether; isoxazoles; monochlorobenzenes; monofluorobenzenes; N-acylpiperidine; pyridines | P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-[5-(5-methyl-2-thiophenyl)-1,3,4-oxadiazol-2-yl]-N-[2-(3-pyridinyloxy)propyl]propanamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
violaceol II | | aromatic ether; catechols; resorcinols | mycotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pamapimod | | aromatic amine; aromatic ether; difluorobenzene; diol; primary alcohol; pyridopyrimidine; secondary amino compound | antirheumatic drug; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gsk690693 | | 1,2,5-oxadiazole; acetylenic compound; aromatic amine; aromatic ether; imidazopyridine; piperidines; primary amino compound; tertiary alcohol | antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cnf 2024 | | 2-aminopurines; aromatic ether; organochlorine compound; pyridines | antineoplastic agent; Hsp90 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
uk 453,061 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
8-{1-[4-(dimethylamino)phenyl]-3-(pyrrolidin-1-yl)propyl}-5,7-dimethoxy-4-pentyl-2H-chromen-2-one | | aromatic ether; coumarins; pyrrolidines; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
zm323881 | | aromatic ether; benzyl ether; fluorophenol; halophenol; monofluorobenzenes; organic cation; quinazolines; secondary amino compound; substituted aniline | vascular endothelial growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
compound w | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-[2-[(2-methylpropan-2-yl)oxy]anilino]-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
interiotherin b | | aromatic ether; fatty acid ester; lignan; organic heteropentacyclic compound; oxacycle | anti-HIV agent; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,7-dihydroxy-3-(3-hydroxy-4-methoxybenzyl)-6-methoxychroman-4-one | | aromatic ether; homoisoflavonoid; polyphenol | angiogenesis modulating agent; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ph 797804 | | aromatic ether; benzamides; organobromine compound; organofluorine compound; pyridone | anti-inflammatory agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diorcinol | | aromatic ether; phenols | fungal metabolite; marine metabolite; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-(2-phenoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-(1-pyrrolidinyl)-6-[2-(trifluoromethoxy)anilino]-1,3,5-triazin-2-yl]amino]ethanol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-(5-chloro-2-ethoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-(5-chloro-2-propan-2-yloxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mk 5108 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-azepanyl-[5-[(4-chloro-3,5-dimethylphenoxy)methyl]-3-isoxazolyl]methanone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-(1-((5-((2,6-dimethylphenoxy)methyl)-3-isoxazolyl)carbonyl)-4-piperidinyl)pyridine | | aromatic amide; aromatic ether; isoxazoles; N-acylpiperidine; pyridines | geroprotector; P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dafadine D | | aromatic amide; aromatic ether; isoxazoles; N-acylpiperidine; organofluorine compound; pyridines | P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[(1-ethyl-3-methyl-4-pyrazolyl)methyl]-N-[4-(2-fluorophenoxy)phenyl]-4-piperidinecarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dafadine O | | aromatic amide; aromatic ether; isoxazoles; N-acylpiperidine; pyridines; ring assembly | P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-[(3,4-dimethylphenoxy)methyl]-N-methyl-N-(4-oxanylmethyl)-3-isoxazolecarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pci 32765 | | acrylamides; aromatic amine; aromatic ether; N-acylpiperidine; pyrazolopyrimidine; tertiary carboxamide | antineoplastic agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
florbetapir f 18 | | (18)F radiopharmaceutical; aromatic ether; organofluorine compound; pyridines; substituted aniline | radioactive imaging agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
AMG-208 | | aromatic ether; quinolines; triazolopyridazine | antineoplastic agent; c-Met tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6-methoxyspirotryprostatin b | | aromatic ether; azaspiro compound; indole alkaloid; indolones | antineoplastic agent; Aspergillus metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lucitanib | | aromatic ether; cyclopropanes; naphthalenecarboxamide; primary amino compound; quinolines | antineoplastic agent; fibroblast growth factor receptor antagonist; vascular endothelial growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
act-132577 | | aromatic ether; organobromine compound; pyrimidines; sulfamides | antihypertensive agent; drug metabolite; endothelin receptor antagonist; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cabozantinib | | aromatic ether; dicarboxylic acid diamide; organofluorine compound; quinolines | antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
poziotinib | | acrylamides; aromatic ether; dichlorobenzene; diether; monofluorobenzenes; N-acylpiperidine; quinazolines; secondary amino compound; substituted aniline | antineoplastic agent; apoptosis inducer; epidermal growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gsk 2126458 | | aromatic ether; difluorobenzene; pyridazines; pyridines; quinolines; sulfonamide | anticoronaviral agent; antineoplastic agent; autophagy inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor; radiosensitizing agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gsk 1363089 | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-cyclohexyl-1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-cyclohexyl-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monepantel | | (trifluoromethyl)benzenes; aromatic ether; aryl sulfide; nitrile; secondary carboxamide | anthelminthic drug; nematicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
an2728 | | aromatic ether; benzoxaborole; nitrile | antipsoriatic; non-steroidal anti-inflammatory drug; phosphodiesterase IV inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
grazoprevir | | aromatic ether; azamacrocycle; carbamate ester; cyclopropanes; lactam; N-sulfonylcarboxamide; quinoxaline derivative | antiviral drug; hepatitis C protease inhibitor; hepatoprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hordatine a | | aromatic ether; benzofurans; dicarboxylic acid diamide; guanidines; phenols | adrenergic antagonist; metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kavain | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-chloro-2-(3,5-dimethylphenyl)-4-(4-methoxyphenoxy)-3-pyridazinone | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tak-632 | | (trifluoromethyl)benzenes; aromatic ether; benzothiazoles; cyclopropylcarboxamide; monofluorobenzenes; nitrile; secondary carboxamide | antineoplastic agent; apoptosis inducer; B-Raf inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; necroptosis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lrrk2-in1 | | aromatic amine; aromatic ether; N-acylpiperidine; N-alkylpiperazine; pyrimidobenzodiazepine; secondary amino compound; tertiary amino compound | antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
quinolobactin | | aromatic ether; monohydroxyquinoline; phenols; quinolinemonocarboxylic acid | bacterial metabolite; siderophore | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
AZD1979 | | aromatic ether; azaspiro compound; carboxamide; N-acylazetidine; oxadiazole; oxaspiro compound; oxetanes | melanin-concentrating hormone receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ML240 | | aromatic amine; aromatic ether; benzimidazoles; primary amino compound; quinazolines; secondary amino compound | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aripiprazole lauroxil | | aromatic ether; delta-lactam; dichlorobenzene; dodecanoate ester; N-alkylpiperazine; N-arylpiperazine; quinolone | H1-receptor antagonist; prodrug; second generation antipsychotic; serotonergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abt-199 | | aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xl765 | | aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
DMH1 | | aromatic ether; pyrazolopyrimidine; quinolines | antineoplastic agent; bone morphogenetic protein receptor antagonist; protein kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide | | aromatic ether; methylpyridines; olefinic compound; quinazolines; secondary amino compound; secondary carboxamide; toluenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pf 4800567 | | aromatic ether; monochlorobenzenes; oxanes; pyrazolopyrimidine | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propenylphosphonic acid | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abt-333 | | aromatic ether; naphthalenes; pyrimidone; sulfonamide | antiviral drug; nonnucleoside hepatitis C virus polymerase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
naloxegol | | aromatic ether; organic heteropentacyclic compound; phenols; polyether; tertiary alcohol | cathartic; mu-opioid receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ceritinib | | aminopyrimidine; aromatic ether; organochlorine compound; piperidines; secondary amino compound; sulfone | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
MK-8353 | | aromatic ether; dihydropyridine; indazoles; methyl sulfide; N-alkylpyrrolidine; pyridines; pyrrolidinecarboxamide; secondary carboxamide; tertiary carboxamide; triazoles | antineoplastic agent; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[(5-methyl-2-furanyl)methylideneamino]-2-phenoxybenzamide | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
saroglitazar | | aromatic ether; methyl sulfide; monocarboxylic acid; pyrroles | hypoglycemic agent; PPARalpha agonist; PPARgamma agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fertaric acid | | aromatic ether; cinnamate ester; dicarboxylic acid; phenols; tetraric acid derivative | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol | | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; tertiary alcohol; triazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pf-06463922 | | aminopyridine; aromatic ether; azamacrocycle; benzamides; cyclic ether; monofluorobenzenes; nitrile; organic heterotetracyclic compound; pyrazoles | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
DDR1-IN-1 | | (trifluoromethyl)benzenes; aromatic ether; benzamides; N-alkylpiperazine; oxindoles; secondary carboxamide | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ldc4297 | | aromatic ether; piperidines; pyrazoles; pyrazolotriazine; secondary amino compound | antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ap20187 | | aromatic ether; carboxylic ester; N-acylpiperidine; tertiary amino compound | ligand | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methysticin | | 2-pyranones; aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
biliatresone | | aromatic ether; aromatic ketone; benzodioxoles; enone; phenols | plant metabolite; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tak 491 | | 1,2,4-oxadiazole; aromatic ether; benzimidazoles; carboxylic ester; cyclic carbonate ester; dioxolane | angiotensin receptor antagonist; antihypertensive agent; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azilsartan | | 1,2,4-oxadiazole; aromatic ether; benzimidazolecarboxylic acid | angiotensin receptor antagonist; antihypertensive agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydrazinocurcumin | | aromatic ether; olefinic compound; polyphenol; pyrazoles | angiogenesis modulating agent; antineoplastic agent; EC 2.3.1.48 (histone acetyltransferase) inhibitor; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mirodenafil | | aromatic ether; N-alkylpiperazine; primary alcohol; pyrrolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cerulomycin | | aldoxime; aromatic ether; bipyridines; pyridine alkaloid | antineoplastic agent; bacterial metabolite; marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
undecylprodigiosin | | alkaloid; aromatic ether; tripyrrole | antibacterial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite; biological pigment; immunosuppressive agent; radiosensitizing agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sb-590885 | | aromatic ether; imidazoles; ketoxime; pyridines; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[4-(trifluoromethoxy)phenyl]methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | | aromatic ether | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
PF-07304814 | | aromatic ether; indolecarboxamide; L-leucine derivative; phosphate monoester; pyrrolidin-2-ones; secondary carboxamide | anticoronaviral agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bupropion | | aromatic ketone; monochlorobenzenes; secondary amino compound | antidepressant; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sk&f-38393 | | benzazepine; catechols; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
monomethylpropion | | aromatic ketone; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
acebutolol | | aromatic amide; ethanolamines; ether; monocarboxylic acid amide; propanolamine; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympathomimetic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
albuterol | | phenols; phenylethanolamines; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alminoprofen | | amino acid; monocarboxylic acid; secondary amino compound; substituted aniline | antipyretic; antirheumatic drug; cyclooxygenase 2 inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alprenolol | | secondary alcohol; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amodiaquine | | aminoquinoline; organochlorine compound; phenols; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; drug allergen; EC 2.1.1.8 (histamine N-methyltransferase) inhibitor; non-steroidal anti-inflammatory drug; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzylhydrochlorothiazide | | benzenes; benzothiadiazine; organochlorine compound; secondary amino compound; sulfonamide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
betahistine | | aminoalkylpyridine; secondary amino compound | H1-receptor agonist; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carvedilol | | carbazoles; secondary alcohol; secondary amino compound | alpha-adrenergic antagonist; antihypertensive agent; beta-adrenergic antagonist; cardiovascular drug; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chloroquine | | aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clenbuterol | | amino alcohol; dichlorobenzene; ethanolamines; primary arylamine; secondary amino compound; substituted aniline | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
clorprenaline | | ethanolamines; monochlorobenzenes; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
desipramine | | dibenzoazepine; secondary amino compound | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diclofenac | | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenfluramine | | (trifluoromethyl)benzenes; secondary amino compound | appetite depressant; serotonergic agonist; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
berotek | | resorcinols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent; tocolytic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
formoterol fumarate | | formamides; phenols; phenylethanolamines; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glafenine | | aminoquinoline; carboxylic ester; glycol; organochlorine compound; secondary amino compound | inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guazatine | | aliphatic nitrogen antifungal agent; guanidines; secondary amino compound | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guvacine | | alpha,beta-unsaturated monocarboxylic acid; beta-amino acid; pyridine alkaloid; secondary amino compound; tetrahydropyridine | GABA reuptake inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | | bromobenzenes; isoquinolines; olefinic compound; secondary amino compound; sulfonamide | EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hydroxychloroquine | | aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isoproterenol | | catechols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ketamine | | cyclohexanones; monochlorobenzenes; secondary amino compound | analgesic; environmental contaminant; intravenous anaesthetic; neurotoxin; NMDA receptor antagonist; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
labetalol | | benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
meclofenamic acid | | aminobenzoic acid; organochlorine compound; secondary amino compound | analgesic; anticonvulsant; antineoplastic agent; antipyretic; antirheumatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mefenamic acid | | aminobenzoic acid; secondary amino compound | analgesic; antipyretic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
metaproterenol | | aralkylamino compound; phenylethanolamines; resorcinols; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n(1), n(12)-diethylspermine | | polyazaalkane; secondary amino compound; substituted spermine; tetramine | antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fenamic acid | | aminobenzoic acid; secondary amino compound | membrane transport modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nemonapride | | benzamides; monochlorobenzenes; monomethoxybenzene; N-alkylpyrrolidine; secondary amino compound; secondary carboxamide; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
oxamniquine | | aromatic primary alcohol; C-nitro compound; quinolines; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pd 158780 | | aromatic amine; bromobenzenes; diamine; pyridopyrimidine; secondary amino compound | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
practolol | | acetamides; ethanolamines; propanolamine; secondary alcohol; secondary amino compound | anti-arrhythmia drug; beta-adrenergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propafenone | | aromatic ketone; secondary alcohol; secondary amino compound | anti-arrhythmia drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
salmeterol xinafoate | | ether; phenols; primary alcohol; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sotalol | | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
xylazine | | 1,3-thiazine; methylbenzene; secondary amino compound | alpha-adrenergic agonist; analgesic; emetic; muscle relaxant; sedative | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylephrine | | phenols; phenylethanolamines; secondary amino compound | alpha-adrenergic agonist; cardiotonic drug; mydriatic agent; nasal decongestant; protective agent; sympathomimetic agent; vasoconstrictor agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,n'-diphenyl-4-phenylenediamine | | N-substituted diamine; secondary amino compound | antioxidant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
methyl n-methylanthranilate | | benzoate ester; methyl ester; secondary amino compound; substituted aniline | animal metabolite; fungal metabolite; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pseudoephedrine | | phenylethanolamines; secondary alcohol; secondary amino compound | anti-asthmatic drug; bronchodilator agent; central nervous system drug; nasal decongestant; plant metabolite; sympathomimetic agent; vasoconstrictor agent; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dyrene | | monochlorobenzenes; organochlorine pesticide; secondary amino compound; triazines | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
propylhexedrine | | secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-aminodiphenylamine | | aromatic amine; secondary amino compound | allergen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyclopentamine | | secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
benzonatate | | benzoate ester; secondary amino compound; substituted aniline | anaesthetic; antitussive | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diisopropanolamine | | aminodiol; secondary alcohol; secondary amino compound | buffer; emulsifier; surfactant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
meglumine | | hexosamine; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cytisine | | alkaloid; bridged compound; lactam; organic heterotricyclic compound; secondary amino compound | nicotinic acetylcholine receptor agonist; phytotoxin; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
octamylamine | | secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
noramidopyrine | | pyrazoles; secondary amino compound | antipyretic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; opioid analgesic; peripheral nervous system drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diphenylamine | | aromatic amine; bridged diphenyl fungicide; secondary amino compound | antifungal agrochemical; antioxidant; carotogenesis inhibitor; EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor; ferroptosis inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spectinomycin | | cyclic acetal; cyclic hemiketal; cyclic ketone; pyranobenzodioxin; secondary alcohol; secondary amino compound | antibacterial drug; antimicrobial agent; bacterial metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
isometheptene | | secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-methylaspartate | | amino dicarboxylic acid; D-alpha-amino acid; D-aspartic acid derivative; secondary amino compound | neurotransmitter agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
colterol | | catechols; ethanolamines; secondary alcohol; secondary amino compound; triol | anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
du-21220 | | benzyl alcohols; polyphenol; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amoscanate | | C-nitro compound; isothiocyanate; secondary amino compound | schistosomicide drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norflurazone | | (trifluoromethyl)benzenes; organochlorine compound; pyridazinone; secondary amino compound | agrochemical; carotenoid biosynthesis inhibitor; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amineptin | | amino acid; carbocyclic fatty acid; carbotricyclic compound; secondary amino compound | antidepressant; dopamine uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bitolterol | | carboxylic ester; diester; ethanolamines; secondary alcohol; secondary amino compound | anti-asthmatic drug; beta-adrenergic agonist; bronchodilator agent; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pendimethalin | | C-nitro compound; secondary amino compound; substituted aniline | agrochemical; environmental contaminant; herbicide | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bupirimate | | aminopyrimidine; pyrimidine fungicide; secondary amino compound; sulfamate ester | androgen antagonist; antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
torsemide | | aminopyridine; N-sulfonylurea; secondary amino compound | antihypertensive agent; loop diuretic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ractopamine | | benzyl alcohols; polyphenol; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
temafloxacin | | amino acid; monocarboxylic acid; N-arylpiperazine; organofluorine compound; quinolone antibiotic; quinolone; secondary amino compound; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
plerixafor | | azacycloalkane; azamacrocycle; benzenes; crown amine; secondary amino compound; tertiary amino compound | anti-HIV agent; antineoplastic agent; C-X-C chemokine receptor type 4 antagonist; immunological adjuvant | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sertraline | | dichlorobenzene; secondary amino compound; tetralins | antidepressant; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nebivolol | | chromanes; diol; organofluorine compound; secondary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aceclofenac | | amino acid; carboxylic ester; dichlorobenzene; monocarboxylic acid; secondary amino compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tubulosine | | beta-carbolines; isoquinoline alkaloid; isoquinolines; phenols; secondary amino compound; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(methylamino)isobutyric acid | | alanine derivative; alpha-amino acid zwitterion; non-proteinogenic alpha-amino acid; secondary amino compound | human urinary metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
caldopentamine | | polyazaalkane; primary amino compound; secondary amino compound | marine metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mepanipyrim | | acetylenic compound; aminopyrimidine; anilinopyrimidine fungicide; secondary amino compound | antifungal agrochemical; aryl hydrocarbon receptor agonist; hepatotoxic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyprodinil | | aminopyrimidine; anilinopyrimidine fungicide; cyclopropanes; secondary amino compound | antifungal agrochemical; aryl hydrocarbon receptor agonist; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pyrimethanil | | aminopyrimidine; anilinopyrimidine fungicide; secondary amino compound | antifungal agrochemical; aryl hydrocarbon receptor agonist; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fluazinam | | (trifluoromethyl)benzenes; aminopyridine; C-nitro compound; chloropyridine; monochlorobenzenes; secondary amino compound | allergen; antifungal agrochemical; apoptosis inducer; environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile | | dimethoxybenzene; nitrile; secondary amino compound | drug metabolite; marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylisopropyladenosine | | aromatic amine; benzenes; hydrocarbyladenosine; purine nucleoside; secondary amino compound | adenosine A1 receptor agonist; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3,4-methylenedioxyethamphetamine | | benzodioxoles; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
beta-n-methylamino-l-alanine | | diamino acid; L-alanine derivative; non-proteinogenic L-alpha-amino acid; secondary amino compound | bacterial metabolite; neurotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nopaline | | amino acid opine; D-glutamic acid derivative; guanidines; L-arginine derivative; secondary amino compound; tricarboxylic acid | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
octopine | | amino acid opine; amino dicarboxylic acid; D-alpha-amino acid zwitterion; D-arginine derivative; guanidines; secondary amino compound | animal metabolite; xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4'-hydroxydiclofenac | | dichlorobenzene; monocarboxylic acid; phenols; secondary amino compound | allergen; drug metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mannopine | | amino acid opine; dicarboxylic acid monoamide; hexitol derivative; L-glutamine derivative; non-proteinogenic L-alpha-amino acid; secondary amino compound | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ezogabine | | carbamate ester; organofluorine compound; secondary amino compound; substituted aniline | anticonvulsant; potassium channel modulator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aj 76 | | secondary amino compound; tetralins | dopaminergic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nsc 224070 | | 1,4-benzoquinones; aziridines; enamine; primary alcohol; secondary amino compound | alkylating agent; antineoplastic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
als 8123 | | carboxylic acid; ethanolamines; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
7-nitrobenzoxadiazole-6-aminohexanoic acid | | benzoxadiazole; C-nitro compound; epsilon-amino acid; secondary amino compound | fluorochrome | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5,5,7,12,12,14-hexamethyl-1,4,8,11-tetrazacyclotetradecane | | secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cox 189 | | amino acid; monocarboxylic acid; organochlorine compound; organofluorine compound; secondary amino compound | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vatalanib | | monochlorobenzenes; phthalazines; pyridines; secondary amino compound | angiogenesis inhibitor; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; vascular endothelial growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cinacalcet | | (trifluoromethyl)benzenes; naphthalenes; secondary amino compound | calcimimetic; P450 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
guvacoline | | alpha,beta-unsaturated carboxylic ester; beta-amino acid ester; enoate ester; methyl ester; pyridine alkaloid; secondary amino compound; tetrahydropyridine | muscarinic agonist; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
baeocystin | | organic phosphate; secondary amino compound; tryptamine alkaloid | fungal metabolite; hallucinogen | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dizocilpine | | secondary amino compound; tetracyclic antidepressant | anaesthetic; anticonvulsant; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
melagatran | | azetidines; carboxamidine; dicarboxylic acid monoamide; non-proteinogenic alpha-amino acid; secondary amino compound | anticoagulant; EC 3.4.21.5 (thrombin) inhibitor; serine protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alpha-putrescinylthymine | | N-substituted putrescine; pyrimidine nucleobase; pyrimidone; secondary amino compound; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
demecolcine | | alkaloid; secondary amino compound | antineoplastic agent; microtubule-destabilising agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
nsc 23766 | | aminopyrimidine; aminoquinoline; primary amino compound; secondary amino compound; tertiary amino compound | antiviral agent; apoptosis inducer; EC 3.6.5.2 (small monomeric GTPase) inhibitor; muscarinic antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
norbelladine | | catechols; phenethylamine alkaloid; polyphenol; secondary amino compound | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
e 3040 | | benzothiazoles; organic hydroxy compound; pyridines; secondary amino compound | anti-inflammatory drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; uricosuric drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
E3040 glucuronide | | benzothiazoles; beta-D-glucosiduronic acid; pyridines; secondary amino compound | xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
validamycin a | | antibiotic fungicide; polyol; secondary amino compound; validamycins | antifungal agrochemical; EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor; EC 2.4.1.64 (alpha,alpha-trehalose phosphorylase) inhibitor; EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ergonovine | | ergot alkaloid; monocarboxylic acid amide; organic heterotetracyclic compound; primary alcohol; secondary amino compound; tertiary amino compound | diagnostic agent; fungal metabolite; oxytocic; toxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
1-[4-carboxy-2-(3-pentylamino)phenyl]-5,5-bis(hydroxymethyl)pyrrolidin-2-one | | benzoic acids; primary alcohol; pyrrolidin-2-ones; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tolfenamic acid | | aminobenzoic acid; organochlorine compound; secondary amino compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; EC 2.7.1.33 (pantothenate kinase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-benzylquinazolin-4-amine | | benzenes; quinazolines; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s 1033 | | (trifluoromethyl)benzenes; imidazoles; pyridines; pyrimidines; secondary amino compound; secondary carboxamide | anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-fluorophenyl)-2-(pyridin-4-yl)quinazolin-4-amine | | aromatic amine; monofluorobenzenes; pyridines; quinazolines; secondary amino compound; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
loline | | loline alkaloid; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
SMER 28 | | organobromine compound; quinazolines; secondary amino compound | autophagy inducer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amn082 | | benzenes; diamine; diarylmethane; secondary amino compound | metabotropic glutamate receptor agonist; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-{3-[(2-phenylquinazolin-4-yl)amino]phenyl}acetamide | | acetamide; aromatic amine; quinazolines; secondary amino compound; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spiraprilat | | azaspiro compound; dicarboxylic acid; dipeptide; dithioketal; pyrrolidinecarboxylic acid; secondary amino compound; tertiary carboxamide | antihypertensive agent; drug metabolite; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
5-hydroxydiclofenac | | dichlorobenzene; monocarboxylic acid; phenols; secondary amino compound | allergen; drug metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dasatinib | | 1,3-thiazoles; aminopyrimidine; monocarboxylic acid amide; N-(2-hydroxyethyl)piperazine; N-arylpiperazine; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
noribogaine | | monoterpenoid indole alkaloid; organic heteropentacyclic compound; secondary amino compound; tertiary amino compound | kappa-opioid receptor agonist; NMDA receptor antagonist; psychotropic drug; serotonin uptake inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
6,8-difluoro-4-(pyridin-3-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline | | organic heterotricyclic compound; organofluorine compound; pyridines; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n,o-didesmethylvenlafaxine | | cyclohexanols; phenols; secondary amino compound | drug metabolite; marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-desmethylvenlafaxine | | cyclohexanols; monomethoxybenzene; secondary amino compound | drug metabolite; marine xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sb 415286 | | C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline | antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(3-{[2-(2-fluorophenyl)quinazolin-4-yl]amino}phenyl)acetamide | | acetamide; aromatic amine; monofluorobenzenes; quinazolines; secondary amino compound; substituted aniline | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-amine | | aromatic amine; piperidines; pyridines; quinazolines; secondary amino compound; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chanoclavine | | benzoindole; ergot alkaloid; organic heterotricyclic compound; primary alcohol; secondary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | | 1,4-benzoquinones; ansamycin; carbamate ester; secondary amino compound; tertiary amino compound | Hsp90 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
spirapril | | azaspiro compound; dicarboxylic acid monoester; dipeptide; dithioketal; ethyl ester; pyrrolidinecarboxylic acid; secondary amino compound; tertiary carboxamide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
palbociclib | | aminopyridine; aromatic ketone; cyclopentanes; piperidines; pyridopyrimidine; secondary amino compound; tertiary amino compound | antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trandolaprilat | | dicarboxylic acid; dipeptide; organic heterobicyclic compound; secondary amino compound; tertiary carboxamide | antihypertensive agent; drug metabolite; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; human xenobiotic metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
amocarzine | | C-nitro compound; N-methylpiperazine; secondary amino compound; thioureas | antinematodal drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
imidapril | | dicarboxylic acid monoester; dipeptide; ethyl ester; imidazolidines; N-acylurea; secondary amino compound | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
imidaprilat | | dicarboxylic acid; dipeptide; imidazolidines; N-acylurea; secondary amino compound | antihypertensive agent; drug metabolite; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ximelagatran | | amidoxime; azetidines; carboxamide; ethyl ester; hydroxylamines; secondary amino compound; secondary carboxamide; tertiary carboxamide | anticoagulant; EC 3.4.21.5 (thrombin) inhibitor; prodrug; serine protease inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
trandolapril | | dicarboxylic acid monoester; dipeptide; ethyl ester; organic heterobicyclic compound; secondary amino compound; tertiary carboxamide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
GSK3-XIII | | aromatic amine; pyrazoles; quinazolines; secondary amino compound | EC 2.7.11.26 (tau-protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
robenacoxib | | aromatic amino acid; monocarboxylic acid; organofluorine compound; phenylacetic acids; secondary amino compound | cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tanespimycin | | 1,4-benzoquinones; ansamycin; carbamate ester; organic heterobicyclic compound; secondary amino compound | antineoplastic agent; apoptosis inducer; Hsp90 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indacaterol | | indanes; monohydroxyquinoline; quinolone; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
panobinostat | | cinnamamides; hydroxamic acid; methylindole; secondary amino compound | angiogenesis modulating agent; antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bis(7)-tacrine | | secondary amino compound | apoptosis inhibitor; EC 1.14.13.39 (nitric oxide synthase) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; neuroprotective agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
r 115866 | | aromatic amine; benzothiazoles; secondary amino compound; triazoles | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pd 0325901 | | difluorobenzene; hydroxamic acid ester; monofluorobenzenes; organoiodine compound; propane-1,2-diols; secondary amino compound | antineoplastic agent; EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
dysiherbaine | | amino dicarboxylic acid; furopyran; hydroxy carboxylic acid; secondary amino compound | animal metabolite; excitatory amino acid agonist; marine metabolite; neurotoxin | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cangrelor | | adenosine 5'-phosphate; aryl sulfide; nucleoside triphosphate analogue; organochlorine compound; organofluorine compound; secondary amino compound | P2Y12 receptor antagonist; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mocetinostat | | aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline | antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ticagrelor | | aryl sulfide; hydroxyether; organofluorine compound; secondary amino compound; triazolopyrimidines | P2Y12 receptor antagonist; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
solabegron | | carboxybiphenyl; monochlorobenzenes; secondary alcohol; secondary amino compound; substituted aniline | beta-adrenergic agonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rucaparib | | azepinoindole; caprolactams; organofluorine compound; secondary amino compound | antineoplastic agent; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chir 99021 | | aminopyridine; aminopyrimidine; cyanopyridine; diamine; dichlorobenzene; imidazoles; secondary amino compound | EC 2.7.11.26 (tau-protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azd 6244 | | benzimidazoles; bromobenzenes; hydroxamic acid ester; monochlorobenzenes; organofluorine compound; secondary amino compound | anticoronaviral agent; antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vilanterol | | benzyl alcohols; dichlorobenzene; ether; phenols; secondary amino compound | beta-adrenergic agonist; bronchodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
binimetinib | | benzimidazoles; bromobenzenes; hydroxamic acid ester; monofluorobenzenes; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-epi-fagomine | | amino monosaccharide; hydroxypiperidine; primary alcohol; secondary alcohol; secondary amino compound; triol | EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor; EC 3.2.1.23 (beta-galactosidase) inhibitor; plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethaboxam | | 1,3-thiazoles; aromatic amide; aromatic amine; nitrile; secondary amino compound; thiophenes | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
abt-737 | | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
validoxylamine a | | amino cyclitol; secondary amino compound | animal metabolite; antibiotic insecticide; bacterial metabolite; EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azd 1152 | | anilide; monoalkyl phosphate; monofluorobenzenes; pyrazoles; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound | antineoplastic agent; Aurora kinase inhibitor; prodrug | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pf 00299804 | | enamide; monochlorobenzenes; monofluorobenzenes; piperidines; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound | antineoplastic agent; epidermal growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
finafloxacin | | cyclopropanes; monocarboxylic acid; nitrile; organofluorine compound; quinolone; secondary amino compound; tertiary amino compound | antibacterial drug; antimicrobial agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
sarpagine | | indole alkaloid; phenols; primary alcohol; secondary amino compound; tertiary amino compound | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
vizamyl | | (18)F radiopharmaceutical; aromatic amine; benzothiazoles; secondary amino compound | radioactive imaging agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
azd 1152-hqpa | | anilide; monofluorobenzenes; primary alcohol; pyrazoles; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound | antineoplastic agent; Aurora kinase inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gdc-0973 | | aromatic amine; difluorobenzene; N-acylazetidine; organoiodine compound; piperidines; secondary amino compound; tertiary alcohol | antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pevonedistat | | cyclopentanols; indanes; pyrrolopyrimidine; secondary amino compound; sulfamidate | antineoplastic agent; apoptosis inducer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tg101209 | | N-alkylpiperazine; N-arylpiperazine; pyrimidines; secondary amino compound; sulfonamide | antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
WAY-316606 | | (trifluoromethyl)benzenes; piperidines; secondary amino compound; sulfonamide; sulfone | secreted frizzled-related protein 1 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
asp3026 | | aromatic amine; diamino-1,3,5-triazine; monomethoxybenzene; N-methylpiperazine; piperidines; secondary amino compound; sulfone | antimalarial; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 6.1.1.6 (lysine--tRNA ligase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
entrectinib | | benzamides; difluorobenzene; indazoles; N-methylpiperazine; oxanes; secondary amino compound; secondary carboxamide | antibacterial agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pexidartinib | | aminopyridine; organochlorine compound; organofluorine compound; pyrrolopyridine; secondary amino compound | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(R)-DRF053 | | 2,6-diaminopurines; phenylpyridine; primary alcohol; secondary amino compound | EC 2.7.11.22 (cyclin-dependent kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
GDC-0623 | | hydroxamic acid ester; imidazopyridine; monofluorobenzenes; organoiodine compound; primary alcohol; secondary amino compound; substituted aniline | antineoplastic agent; apoptosis inducer; EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cblc137 | | aromatic ketone; carbazoles; methyl ketone; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; NF-kappaB inhibitor; p53 activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mephedrone | | amphetamines; aromatic ketone; secondary amino compound | environmental contaminant; xenobiotic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ml228 probe | | 1,2,4-triazines; biphenyls; pyridines; secondary amino compound | hypoxia-inducible factor pathway activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gilteritinib | | aromatic amine; monomethoxybenzene; N-methylpiperazine; oxanes; piperidines; primary carboxamide; pyrazines; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chir 98014 | | aminopyrimidine; C-nitro compound; diaminopyridine; dichlorobenzene; imidazoles; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; hypoglycemic agent; tau aggregation inhibitor; Wnt signalling activator | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
AZD3463 | | aminopiperidine; aminopyrimidine; indoles; monomethoxybenzene; organochlorine compound; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
gsk2879552 | | benzenes; benzoic acids; cyclopropanes; monocarboxylic acid; piperidines; secondary amino compound; tertiary amino compound | antineoplastic agent; EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ML355 | | benzothiazoles; monomethoxybenzene; phenols; secondary amino compound; substituted aniline; sulfonamide | EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; platelet aggregation inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
osimertinib | | acrylamides; aminopyrimidine; biaryl; indoles; monomethoxybenzene; secondary amino compound; secondary carboxamide; substituted aniline; tertiary amino compound | antineoplastic agent; epidermal growth factor receptor antagonist | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ly3009120 | | aminotoluene; aromatic amine; biaryl; monofluorobenzenes; phenylureas; pyridopyrimidine; secondary amino compound | antineoplastic agent; apoptosis inducer; autophagy inducer; B-Raf inhibitor; necroptosis inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
as 1842856 | | organofluorine compound; primary amino compound; quinolinemonocarboxylic acid; quinolone; secondary amino compound; tertiary amino compound | anti-obesity agent; antineoplastic agent; apoptosis inducer; autophagy inhibitor; forkhead box protein O1 inhibitor; hypoglycemic agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
hg-9-91-01 | | aminopyrimidine; dimethoxybenzene; N-alkylpiperazine; N-arylpiperazine; phenylureas; secondary amino compound | antineoplastic agent; salt-inducible kinase 2 inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
praliciguat | | aminopyrimidine; isoxazoles; monofluorobenzenes; organofluorine compound; pyrazoles; secondary amino compound; tertiary alcohol | anti-inflammatory agent; antihypertensive agent; soluble guanylate cyclase activator; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
chrysopine | | amino acid opine; carboxamide; delta-lactone; secondary amino compound; spiroketal; triol | plant metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
enasidenib | | 1,3,5-triazines; aminopyridine; aromatic amine; organofluorine compound; secondary amino compound; tertiary alcohol | antineoplastic agent; EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
BDA-366 | | anthraquinone; epoxide; secondary alcohol; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
THZ531 | | aminopyrimidine; enamide; indoles; N-acylpiperidine; organochlorine compound; secondary amino compound; secondary carboxamide | antineoplastic agent; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
indolmycin | | 1,3-oxazoles; indoles; secondary amino compound | antibacterial agent; antimicrobial agent; bacterial metabolite; EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ethirimol | | aminopyrimidine; pyrimidine fungicide; pyrimidone; secondary amino compound | antifungal agrochemical | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
liproxstatin-1 | | azaspiro compound; monochlorobenzenes; organic heterotricyclic compound; secondary amino compound | antioxidant; cardioprotective agent; ferroptosis inhibitor; radical scavenger | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |